Rank,Term name,P-value,Z-score,Combined score,Overlapping genes,Adjusted p-value,Old p-value,Old adjusted p-value,gene count
1,Cytoplasmic Ribosomal Proteins WP477,4.31256650714569e-12,4.694978710908824,122.86518862101997,"['RPL4', 'RPL5', 'RPL30', 'RPL3', 'RPL32', 'RPLP1', 'RPL12', 'RPLP0', 'MRPL19', 'RPL8', 'RPS15', 'RPS6KA6', 'RPS16', 'RPL18A', 'RPS19', 'RPS18', 'RPS6KA2', 'RPL36', 'RPL14', 'RPL35', 'RPLP2', 'RPL13', 'RPL38', 'RPS10', 'RPS13', 'RPS12', 'RPL19', 'RPS9', 'RPS5', 'RPS6', 'RPL13A', 'RPL23A', 'RPS26', 'RPS25', 'RPS28', 'RPS6KB1', 'RPS29', 'RPL27A', 'RPL37A', 'RPS20', 'RPL26', 'RPL28', 'UBA52', 'RPS21', 'RPS24']",2.4150372440015864e-09,0,0,45
2,Glycolysis in senescence WP5049,0.00014589720756614263,11.574199368516012,102.23036873675697,"['RB1', 'LDHA', 'PRKAA1', 'G6PD', 'PKM', 'ALDOC', 'ENO1', 'GAPDH']",0.04085121811851994,0,0,8
3,Histone Modifications WP2369,0.0010172197694296734,2.79422461448938,19.254113504990226,"['SETD5', 'KMT2D', 'SETD2', 'KMT2A', 'SETD9', 'EED', 'SETD6', 'KMT2C', 'KMT2B', 'SETD1A', 'SETDB2', 'EHMT1', 'ASH1L', 'SETBP1', 'AEBP2', 'NSD1', 'SMYD3', 'HIST1H4C']",0.18988102362687234,0,0,18
4,Mesodermal commitment pathway WP2857,0.00589732314563815,1.7403412969283276,8.933618683924768,"['YAP1', 'MACF1', 'SETD2', 'PHF6', 'ACACA', 'MBTD1', 'EPB41L5', 'ZIC2', 'HNF4A', 'UBR5', 'CEP250', 'RPL38', 'DIP2A', 'PRKACA', 'KDM6A', 'SMAD2', 'SMAD4', 'TBX6', 'ELP4', 'EMSY', 'ACVR2A', 'PARP8', 'LATS1', 'EXT2', 'CCDC88A', 'DDAH1', 'AEBP2', 'BHLHE40', 'RARB', 'PLCH1', 'WDFY2', 'TOX', 'AHDC1', 'BMPR1A']",0.6409122146589729,0,0,34
5,Glycogen Synthesis and Degradation WP500,0.008754550371938466,2.431349152542373,11.520173991059897,"['GSK3A', 'GBE1', 'PPP2R2A', 'PHKB', 'PPP2R5C', 'PHKA2', 'GYS2', 'GYS1', 'PHKG1', 'PPP2R1B', 'PPP2R2B', 'PHKG2', 'CALM1', 'CALM2']",0.6409122146589729,0,0,14
6,Regulation of Microtubule Cytoskeleton WP2038,0.009102838191257958,2.3261517221334107,10.930980119954153,"['TRIO', 'ROCK1', 'PTEN', 'TIAM1', 'PARD6A', 'APC', 'CFL2', 'TAOK1', 'GNAQ', 'MAPKAPK2', 'ABL1', 'PRKACA', 'CLASP1', 'MARK2', 'MARK1']",0.6409122146589729,0,0,15
7,Pathways affected in adenoid cystic carcinoma WP3651,0.009312941179241764,2.020664812942366,9.449336547538627,"['MAGI1', 'CEBPA', 'SETD2', 'CREBBP', 'KMT2C', 'MGA', 'MAGI2', 'PTEN', 'ERBIN', 'JMJD1C', 'ARID4B', 'SMC1A', 'FOXO3', 'SMARCA2', 'NCOR1', 'NSD1', 'EP300', 'ATM', 'RAF1', 'KDM6A']",0.6409122146589729,0,0,20
8,Type 2 papillary renal cell carcinoma WP4241,0.013192965711412723,2.480061943476578,10.7338853961594,"['EGLN1', 'SETD2', 'TGFB2', 'CREBBP', 'EPAS1', 'CADM2', 'CTSK', 'DVL2', 'TFEB', 'EP300', 'ARNT', 'COL21A1']",0.6409122146589729,0,0,12
9,MECP2 and Associated Rett Syndrome WP3584,0.013405375640407079,1.9305555555555556,8.324747617409297,"['GRIA1', 'RBFOX1', 'GRID1', 'DHX9', 'HDAC1', 'RPS6', 'PTEN', 'TET2', 'IGF1', 'SMC3', 'MYT1', 'MECP2', 'FUT8', 'NCOR1', 'SP1', 'E2F1', 'NF1', 'SGK1', 'GRIA3', 'CDON']",0.6409122146589729,0,0,20
10,Angiopoietin Like Protein 8 Regulatory Pathway WP3915,0.013668795966230841,1.6306294779938588,6.999704850633258,"['GSK3A', 'PRKAA1', 'THRB', 'PIK3R4', 'PRKAG2', 'IRS2', 'CBLB', 'PIK3CB', 'FOXO3', 'CBL', 'RPTOR', 'GYS1', 'MAPK9', 'RPS6KA6', 'MAPK8', 'RXRA', 'RPS6KA2', 'MAP3K8', 'MAP4K5', 'MAPK6', 'MAP3K7', 'MAP3K4', 'MAP4K3', 'MAP2K6', 'MAP4K4', 'MAP3K1', 'INSR', 'MLXIPL', 'RPS6KB1', 'MAP3K10', 'RAF1', 'MAP3K14', 'MAP3K12']",0.6409122146589729,0,0,33
11,Metabolic reprogramming in colon cancer WP4290,0.01412315965370065,2.2508976773383553,9.588687476966388,"['TIGAR', 'G6PD', 'PGAM1', 'GOT2', 'ENO1', 'PAICS', 'GLS', 'RPIA', 'ACLY', 'LDHA', 'PKM', 'TKT', 'GAPDH', 'IDH3A']",0.6409122146589729,0,0,14
12,"GPCRs, Class C Metabotropic glutamate, pheromone WP501",0.014215330267237975,4.336375929682218,18.444490118893363,"['GRM3', 'GPRC5B', 'GRM4', 'GRM7', 'GPRC5C', 'GRM1']",0.6409122146589729,0,0,6
13,Thiamine metabolic pathways WP4297,0.014905497675483421,5.4194829334234536,22.79448158612491,"['BCKDK', 'TPK1', 'SLC19A3', 'OGDH', 'TKT']",0.6409122146589729,0,0,5
14,Hematopoietic Stem Cell Gene Regulation by GABP alpha/beta Complex WP3657,0.01602280536647432,3.1546315659982778,13.04043374390333,"['SMAD4', 'DNMT1', 'CREBBP', 'PTEN', 'EP300', 'ATM', 'FOXO3', 'ETV6']",0.6409122146589729,0,0,8
15,Lipid Metabolism Pathway WP3965,0.019970669413204564,2.5520729618861764,9.98751357537407,"['LIPE', 'ACLY', 'PRKAA1', 'ACSS2', 'PRKAR2A', 'HILPDA', 'AKT3', 'PRKAG2', 'PRKACA', 'ACACA']",0.6876515350532767,0,0,10
16,Ciliopathies WP4803,0.025201391466279924,1.4497318269998858,5.336254193941234,"['INVS', 'C2CD3', 'IFT172', 'CEP120', 'DNAH6', 'PIK3R4', 'PKD2', 'PKD1', 'CCDC28B', 'TTBK2', 'PKHD1', 'FLCN', 'ZIC2', 'TBC1D32', 'SUFU', 'NPHP4', 'RAB28', 'PIBF1', 'CEP290', 'TAPT1', 'CEP78', 'DYNC2H1', 'IQCB1', 'CFAP52', 'WDR19', 'SCLT1', 'DNAAF5', 'CPLANE1', 'ICK', 'AHI1', 'TTLL5', 'WDR60', 'NME7', 'KIAA0586', 'ALMS1', 'SPAG1', 'WDPCP', 'CCDC65', 'B9D2', 'CCNQ', 'CCDC151', 'KIZ', 'SDCCAG8']",0.6876515350532767,0,0,43
17,Cell cycle WP179,0.025921232281572375,1.570699977825412,5.737284605044136,"['RB1', 'YWHAE', 'ANAPC13', 'CDKN1B', 'HDAC1', 'CUL1', 'SMC3', 'CDC14A', 'ANAPC10', 'ANAPC11', 'CCNB3', 'ORC5', 'ORC2', 'ABL1', 'E2F1', 'EP300', 'SKP2', 'YWHAG', 'SMAD2', 'TGFB2', 'SMAD4', 'SMC1A', 'CDC25B', 'MAD2L2', 'CCNA1', 'RBL1', 'CCNE2', 'MCM3', 'ATM', 'MAD1L1']",0.6876515350532767,0,0,30
18,Autophagy WP4923,0.025969866502750984,2.4101030617618293,8.798848588741109,"['RPTOR', 'UVRAG', 'PRKAA1', 'MAP1LC3B', 'ATG101', 'ATG9A', 'PIK3R4', 'PRKAG2', 'AMBRA1', 'WIPI2']",0.6876515350532767,0,0,10
19,Rett syndrome causing genes WP4312,0.02598488554091905,1.9729338142359505,7.201682390396776,"['KDM5B', 'SRRM3', 'CDKL5', 'HDAC1', 'SMC1A', 'SMARCA2', 'GRIN2B', 'SYNE2', 'MECP2', 'GRIN2A', 'NCOR1', 'TAF1B', 'IMPDH2', 'SCN2A', 'GABRD']",0.6876515350532767,0,0,15
20,DDX1 as a regulatory component of the Drosha microprocessor WP2942,0.026705999185372573,5.7792792792792795,20.937560474942636,"['MRE11', 'DDX1', 'DROSHA', 'ATM']",0.6876515350532767,0,0,4
21,Pentose Phosphate Metabolism WP134,0.026705999185372573,5.7792792792792795,20.937560474942636,"['RPIA', 'G6PD', 'PGLS', 'TKT']",0.6876515350532767,0,0,4
22,GDNF/RET signaling axis WP4830,0.027230135954930262,3.035542779844437,10.938368892406162,"['SALL1', 'SOX11', 'GFRA1', 'SPRY1', 'SLIT2', 'FAT4', 'PAX2']",0.6876515350532767,0,0,7
23,3q29 copy number variation syndrome WP4906,0.029088144719700598,1.8449355276552426,6.5263202946738375,"['DYNC2H1', 'GRIA1', 'STAT5B', 'DYNLT1', 'NCBP2', 'MYCBP2', 'MAD2L1BP', 'FBXO45', 'SIRT1', 'DYNLL2', 'PIGX', 'TF', 'WDR60', 'UBE2N', 'UBXN7', 'PIGM', 'PAK2']",0.6876515350532767,0,0,17
24,NAD Metabolism in Oncogene-Induced Senescence and Mitochondrial Dysfunction-Associated Senescence WP5046,0.030374552555559004,2.668887269699178,9.32549274195574,"['RB1', 'PRKAA1', 'G6PD', 'MDH1', 'SCO2', 'GOT2', 'HMGA1', 'SIRT1']",0.6876515350532767,0,0,8
25,Circadian rhythm related genes WP3594,0.032027103923450054,1.4267036704312115,4.909533774572224,"['KDM5A', 'NLGN1', 'PRKAA1', 'PHLPP1', 'AHCY', 'CHRM1', 'KMT2A', 'DHX9', 'HDAC1', 'CUL1', 'PTEN', 'OPRL1', 'RBM4B', 'ARNTL2', 'NPAS2', 'ARNTL', 'ATOH7', 'MAPK9', 'MAPK8', 'EP300', 'BTRC', 'PPARGC1A', 'DRD3', 'KCNH7', 'ARNT', 'BTBD9', 'SIRT1', 'NR2F6', 'SETX', 'PER1', 'NCOR1', 'PER3', 'ADORA2A', 'GNAQ', 'KCNMA1', 'BHLHE40', 'ID3', 'GHRL', 'TOP1', 'ATF5', 'PPARA', 'UBA52']",0.6876515350532767,0,0,42
26,7q11.23 copy number variation syndrome WP4932,0.03240912717602391,1.5906768041879595,5.454932131581043,"['RB1', 'TSG101', 'CLTC', 'UBE2L6', 'ACACA', 'CFL1', 'BCL7B', 'MVB12A', 'CLASP1', 'GTF2I', 'CLASP2', 'BRD4', 'ATPAF2', 'RFC2', 'UBE2E1', 'FZD9', 'HMGA1', 'SMARCA5', 'VPS37A', 'HSPA2', 'ATP5F1D', 'MLXIPL', 'TBL2', 'OGDH', 'ERCC6', 'GAPDH']",0.6876515350532767,0,0,26
27,Sleep regulation WP3591,0.03315462758292584,2.2830773616505717,7.777469644213597,"['CACNA1I', 'NLGN1', 'GRIN2A', 'AHCY', 'PER3', 'ADORA2A', 'GHRL', 'BTBD9', 'DRD3', 'NPAS2']",0.6876515350532767,0,0,10
28,Fragile X Syndrome  WP4549,0.036168494707335776,1.5155514338707377,5.030974300929185,"['GRIA1', 'SH3GL3', 'ABCD3', 'KCNC1', 'CLTC', 'AGAP2', 'ITPR1', 'PTEN', 'PIK3CB', 'GPHN', 'GRM1', 'MECP2', 'RPTOR', 'GRIN2A', 'MKNK1', 'FYN', 'PRKACA', 'GABRD', 'SH3GL1', 'EPHA4', 'DUSP3', 'DICER1', 'GRIN2B', 'DNM2', 'RPS6KB1', 'NF1', 'KRAS', 'RAF1', 'EIF4G1', 'HCN1']",0.7233698941467155,0,0,30
29,Transcription factor regulation in adipogenesis WP3599,0.03751643423487568,2.759369139484121,9.05894320019771,"['CEBPA', 'MAPK8', 'RXRA', 'INSR', 'IRS2', 'LPIN1', 'PPARGC1A']",0.7244552817769098,0,0,7
30,Pathways in clear cell renal cell carcinoma WP4018,0.04587432081362184,1.591921595286653,4.906063214820082,"['SETD2', 'TGFB2', 'CREBBP', 'KSR1', 'MDH1', 'PTEN', 'ARNT', 'ENO1', 'ENO2', 'ACACA', 'RPTOR', 'ACLY', 'LDHB', 'LDHA', 'PKM', 'ME1', 'EP300', 'ALDOC', 'ENPP3', 'RAPGEF5', 'CEP290', 'GAPDH']",0.8563206551876077,0,0,22
31,Insulin Signaling WP481,0.06054282127094839,1.3738637325928067,3.85286946193568,"['GSK3A', 'PRKAA1', 'INPPL1', 'PIK3R4', 'PTEN', 'IRS2', 'CBLB', 'PIK3CB', 'FOXO3', 'CBL', 'GYS2', 'LIPE', 'GYS1', 'MAPK9', 'RPS6KA6', 'MAPK8', 'RPS6KA2', 'MAP3K8', 'MAP4K5', 'MAPK6', 'MAP3K7', 'MAP3K4', 'MAP4K3', 'MAP2K6', 'MAP4K4', 'RAB4A', 'MAP3K1', 'INSR', 'INPP4A', 'RPS6KB1', 'RHOJ', 'MAP3K10', 'RAF1', 'SGK1', 'MAP3K14', 'MAP3K12', 'ARF6']",0.9837982268107555,0,0,37
32,Translation inhibitors in chronically activated PDGFRA cells WP4566,0.06571356213815215,1.7622522026431717,4.797643420191017,"['EIF4A2', 'RPS6', 'PIK3CB', 'RPTOR', 'MAPK9', 'MAPK8', 'RPS6KB1', 'RPS6KA2', 'AKT3', 'PIM2', 'PRKACA', 'MAP2K6', 'EIF4G1']",0.9837982268107555,0,0,13
33,Splicing factor NOVA regulated synaptic proteins WP4148,0.06899890184022042,1.7947855340622372,4.798654708312845,"['MAPK9', 'KCNJ6', 'CDH2', 'CAV2', 'APLP2', 'CLSTN1', 'KCNMA1', 'CASK', 'ANK3', 'GRIN2B', 'GPHN', 'CLASP1']",0.9837982268107555,0,0,12
34,Prolactin Signaling Pathway WP2037,0.06974801459879693,1.5556908094948265,4.14259666594533,"['ITGB1', 'STAT5B', 'CISH', 'RPS6', 'AGAP2', 'IRS2', 'PIK3CB', 'CBL', 'PRLR', 'PTK2', 'SOCS2', 'MAPK9', 'MAPK8', 'RPS6KB1', 'RPS6KA2', 'FYN', 'PTPN6', 'RAF1', 'YWHAG']",0.9837982268107555,0,0,19
35,Biotin Metabolism (including IEMs) WP5031,0.0701288752940061,3.467027027027027,9.213349229620642,"['PCCA', 'HLCS', 'MCCC1', 'ACACA']",0.9837982268107555,0,0,4
36,Cytosine methylation WP3585,0.0701288752940061,3.467027027027027,9.213349229620642,"['MECP2', 'MBD3', 'DNMT1', 'TET2']",0.9837982268107555,0,0,4
37,Methionine metabolism leading to sulfur amino acids and related disorders WP4292,0.0701288752940061,3.467027027027027,9.213349229620642,"['AHCY', 'ADK', 'MAT2B', 'GNMT']",0.9837982268107555,0,0,4
38,Trans-sulfuration pathway WP2333,0.0701288752940061,3.467027027027027,9.213349229620642,"['MPST', 'DNMT1', 'AHCY', 'MAT2B']",0.9837982268107555,0,0,4
39,Senescence and Autophagy in Cancer WP615,0.07252088330655507,1.4919591264445955,3.9147227764489094,"['RB1', 'SH3GLB1', 'UVRAG', 'SMAD4', 'RNASEL', 'SPARC', 'CDKN1B', 'GSN', 'KMT2A', 'ATG10', 'HMGA1', 'PTEN', 'IGF1', 'AMBRA1', 'CDC25B', 'RSL1D1', 'MAP1LC3B', 'LAMP1', 'LAMP2', 'E2F1', 'RAF1', 'SLC39A1']",0.9837982268107555,0,0,22
40,Alzheimer's disease WP2059,0.07361997522072303,1.5226926010678872,3.9724596715492555,"['APAF1', 'ITPR1', 'ATP2A2', 'CACNA1D', 'IDE', 'CACNA1C', 'GRIN2B', 'RYR3', 'APH1A', 'GRIN2A', 'PPP3CC', 'PPP3R2', 'GNAQ', 'CAPN2', 'NOS1', 'CAPN1', 'CALM1', 'ATF6', 'GAPDH', 'CALM2']",0.9837982268107555,0,0,20
41,Joubert Syndrome WP4656,0.07836892125034062,1.5267622461170849,3.8876372166867563,"['INVS', 'MRE11', 'PDE6G', 'CEP120', 'ARMC9', 'ARL2', 'MYO5A', 'CPLANE1', 'AHI1', 'NIN', 'KAT5', 'KIAA0586', 'SUFU', 'NPHP4', 'ATM', 'B9D2', 'CEP290', 'PIBF1', 'RAB8A']",0.9837982268107555,0,0,19
42,Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway WP4577,0.08077868689757557,1.7348238482384823,4.364889880356563,"['RPTOR', 'MECP2', 'PRKAA1', 'DCAF17', 'SCP2', 'ATG101', 'PIK3R4', 'ATG10', 'WIPI2', 'GTPBP2', 'ACACA', 'FTL']",0.9837982268107555,0,0,12
43,Canonical and non-canonical TGF-B signaling WP3874,0.08210438600393305,2.3643739627512446,5.910376539272606,"['SMAD2', 'MAPK9', 'SMAD4', 'MAPK8', 'BMP1', 'BMPR1A']",0.9837982268107555,0,0,6
44,Proteoglycan biosynthesis WP4784,0.08210438600393305,2.3643739627512446,5.910376539272606,"['CSGALNACT1', 'EXT2', 'CANT1', 'CHSY1', 'B3GAT3', 'B3GALT6']",0.9837982268107555,0,0,6
45,FTO Obesity Variant Mechanism WP3407,0.08423521861820903,4.332995609591355,10.720447167959176,"['FTO', 'PRDM16', 'PPARGC1A']",0.9837982268107555,0,0,3
46,Insulin signaling in adipocytes (diabetic condition) WP3635,0.08423521861820903,4.332995609591355,10.720447167959176,"['RPS6KB1', 'INSR', 'RPS6']",0.9837982268107555,0,0,3
47,Insulin signaling in adipocytes (normal condition) WP3634,0.08423521861820903,4.332995609591355,10.720447167959176,"['RPS6KB1', 'INSR', 'RPS6']",0.9837982268107555,0,0,3
48,Synaptic signaling pathways associated with autism spectrum disorder WP4539,0.08835287823764787,1.6583311738792432,4.023802127858322,"['PRKAA1', 'PTEN', 'PRKAG2', 'PIK3CB', 'CACNA1C', 'GRIN2B', 'GRM1', 'RPTOR', 'GRIN2A', 'RPS6KB1', 'AKT3', 'NF1', 'KRAS']",0.9837982268107555,0,0,13
49,TNF-alpha signaling pathway WP231,0.08916009692028584,1.4465216406072967,3.4967081273868637,"['CREBBP', 'MAP3K1', 'APAF1', 'KSR1', 'CUL1', 'TNFAIP3', 'OTUD7B', 'KSR2', 'MAPK9', 'MAPK8', 'PSMD2', 'RFK', 'MADD', 'MAP3K8', 'KRAS', 'BTRC', 'RAF1', 'RFFL', 'NFKBIE', 'MAP3K7', 'MAP3K14', 'MAP2K6']",0.9837982268107555,0,0,22
50,VEGFA-VEGFR2 Signaling Pathway WP3888,0.0892238309579316,1.1913727243352823,2.879079798519435,"['ITGB1', 'YWHAE', 'RPL5', 'ARF4', 'FAF1', 'CLTC', 'ARRB2', 'LDB2', 'RPL18A', 'CFL1', 'CAPN2', 'RPLP2', 'LRRFIP2', 'IER5', 'CGNL1', 'ACOT9', 'PRKCE', 'RPS6', 'ARNT', 'RPL13A', 'SND1', 'EPN1', 'RCN1', 'EWSR1', 'KATNAL2', 'MAPKAPK2', 'RHOJ', 'MYH9', 'TNFRSF25', 'RPL26', 'ERG', 'TKT', 'EZR', 'ATP6V0D1', 'RAF1', 'ATF6', 'GAPDH', 'FJX1', 'ARF6', 'LRRC59', 'PRKAA1', 'ROCK1', 'HDAC1', 'FLII', 'NOTCH4', 'HTRA1', 'FOXO3', 'CBL', 'FUT1', 'GIGYF2', 'APOLD1', 'ACACA', 'DLL4', 'MAPK9', 'LDHA', 'MAPK8', 'MKNK1', 'FAM120A', 'ABL1', 'S1PR1', 'DNAJB9', 'FLNB', 'FYN', 'CSK', 'ABCF2', 'PAK2', 'BRD4', 'MAP2K6', 'RBM39', 'CREBBP', 'RAB4A', 'PRRC2C', 'TRIP4', 'SMARCA2', 'QKI', 'PTK2', 'RAB11A', 'FMNL3', 'ITCH', 'RPS6KB1', 'SPIRE1', 'PTPN9', 'PTPN6', 'COPG1', 'EIF4G2', 'EIF4G1']",0.9837982268107555,0,0,86
51,Prion disease pathway WP3995,0.09406349383275085,1.858158085569253,4.392286690502898,"['RXRA', 'HSPA5', 'BCL11A', 'EP300', 'NCAM1', 'FYN', 'SMC3', 'CHD2', 'PTK2']",0.9837982268107555,0,0,9
52,AMP-activated protein kinase (AMPK) signaling WP1403,0.09481169384699263,1.5423488617518468,3.6335618831250946,"['PRKAA1', 'INSR', 'PRKAG2', 'PIK3CB', 'CPT1C', 'ADIPOR1', 'ADRA1A', 'ACACA', 'GYS2', 'RPTOR', 'GYS1', 'LIPE', 'CCNA1', 'EEF2K', 'RPS6KB1', 'HNF4A']",0.9837982268107555,0,0,16
53,Glucocorticoid Receptor Pathway WP2880,0.09481169384699263,1.5423488617518468,3.6335618831250946,"['SRGN', 'ABHD2', 'PLK2', 'CUL1', 'TNFAIP3', 'AKAP13', 'FGD4', 'RXRA', 'ZIC2', 'NAV3', 'ADGRF4', 'DNER', 'ENC1', 'BHLHE40', 'STOM', 'SPRY1']",0.9837982268107555,0,0,16
54,Endoderm differentiation WP2853,0.09621171201624103,1.3655818510240945,3.1971059407409332,"['PHF6', 'ACACA', 'CDC73', 'MBTD1', 'EPB41L5', 'CAND1', 'UBR5', 'CEP250', 'DIP2A', 'BPTF', 'SMAD2', 'SMAD4', 'SFMBT1', 'FOXN3', 'ELP4', 'EMSY', 'PARP8', 'MAD2L2', 'TNRC6C', 'DDAH1', 'AEBP2', 'APC', 'PLCH1', 'WDFY2', 'NAA15', 'TOX', 'AHDC1', 'BMPR1A']",0.9837982268107555,0,0,28
55,Intracellular trafficking proteins involved in CMT neuropathy WP4856,0.09825271897443598,1.9267779281311082,4.470533953373422,"['FGD4', 'RAB4A', 'MFN2', 'KIF1B', 'SBF2', 'GDAP1', 'RAB11A', 'DNM2']",0.9837982268107555,0,0,8
56,Adipogenesis WP236,0.1001447474477251,1.3761061946902655,3.1666111718828724,"['RB1', 'CEBPA', 'EPAS1', 'CELF1', 'ASIP', 'IRS2', 'LIPE', 'RXRA', 'E2F1', 'PPARGC1A', 'FZD1', 'STAT5B', 'MBNL1', 'HMGA1', 'LIFR', 'IGF1', 'PRLR', 'KLF15', 'BSCL2', 'BMP1', 'RBL1', 'NCOR1', 'SP1', 'ID3', 'PPARA', 'LPIN1']",0.9837982268107555,0,0,26
57,PKC-gamma calcium signaling pathway in ataxia WP4760,0.10189338777682824,2.0229060985232783,4.619970054837503,"['GRIA1', 'GNAQ', 'ITPR1', 'CACNA1A', 'RYR3', 'GRM1', 'GRIA3']",0.9837982268107555,0,0,7
58,Urea cycle and associated pathways WP4595,0.10189338777682824,2.0229060985232783,4.619970054837503,"['SLC25A15', 'LDHB', 'MDH1', 'CPS1', 'GOT2', 'NOS1', 'SLC25A12']",0.9837982268107555,0,0,7
59,Type II diabetes mellitus WP1584,0.1046163513056633,2.4077203259359394,5.4353212932104435,"['SURF1', 'MAPK8', 'INSR', 'CACNA1A', 'PHKA2']",0.9929687581554482,0,0,5
60,Envelope proteins and their potential roles in EDMD physiopathology WP4535,0.10791002467974352,1.626143292682927,3.6205389364102127,"['SMAD2', 'TGFB2', 'SMAD4', 'SUN1', 'CFL1', 'KRAS', 'LEMD3', 'EMD', 'LBR', 'SYNE2', 'ADCY5', 'PLEC']",0.9996167817520385,0,0,12
61,Regulation of Actin Cytoskeleton WP51,0.11152525681566824,1.310406960282118,2.8743831648075915,"['CHRM3', 'CHRM1', 'ROCK1', 'PIK3R4', 'PIK3CB', 'ARHGAP35', 'FGD1', 'CFL2', 'CFL1', 'RAC3', 'PIP5K1B', 'CSK', 'PIP4K2C', 'CD14', 'MAPK6', 'PAK2', 'WASF2', 'PAK5', 'GSN', 'ACTN1', 'MSN', 'RRAS2', 'SSH2', 'SSH3', 'PTK2', 'SSH1', 'DIAPH3', 'APC', 'ARHGEF4', 'KRAS', 'EZR', 'RAF1']",0.9996167817520385,0,0,32
62,Energy Metabolism WP1541,0.12325419731405347,1.5767430401576743,3.300921663625946,"['PRKAA1', 'RXRA', 'PPP3CC', 'PPP3R2', 'HDAC1', 'PRKAG2', 'EP300', 'NRF1', 'FOXO3', 'PPARA', 'PPARGC1A', 'SIRT1']",0.9996167817520385,0,0,12
63,Caloric restriction and aging WP4191,0.12738216165489355,3.2494934143870315,6.695787731322578,"['IGF1', 'PPARGC1A', 'SIRT1']",0.9996167817520385,0,0,3
64,Cholesterol Biosynthesis with Skeletal Dysplasias WP4804,0.12738216165489355,3.2494934143870315,6.695787731322578,"['EBP', 'DHCR24', 'LBR']",0.9996167817520385,0,0,3
65,Imatinib and Chronic Myeloid Leukemia WP3640,0.12948021944055,2.000312061163988,4.089092234189821,"['CDKN1B', 'KIT', 'ABL1', 'PIM2', 'FOXO3', 'SKP2']",0.9996167817520385,0,0,6
66,CAMKK2  Pathway WP4874,0.13058925390701664,1.696314279408519,3.453184176303774,"['RPTOR', 'CHRM3', 'EP300', 'NOS1', 'SMC1A', 'RAF1', 'CALM1', 'SIRT1', 'CALM2']",0.9996167817520385,0,0,9
67,TGF-beta Signaling Pathway WP366,0.13374255803350826,1.297332232740301,2.610022979335356,"['ITGB1', 'YAP1', 'CITED1', 'ROCK1', 'ZFYVE9', 'HDAC1', 'CUL1', 'MAPK9', 'MAPK8', 'PARD6A', 'PRKAR2A', 'EP300', 'BTRC', 'MAP3K7', 'PAK2', 'MAP2K6', 'NUP214', 'SMAD2', 'KLF11', 'SMAD4', 'CREBBP', 'NUP153', 'PIAS2', 'PTK2', 'ITCH', 'RBL1', 'SP1', 'RAF1', 'DCP1A']",0.9996167817520385,0,0,29
68,Interactome of polycomb repressive complex 2 (PRC2)  WP2916,0.13374933483482204,2.166779317336938,4.359100339819552,"['SETX', 'MORC3', 'AEBP2', 'EED', 'STK38']",0.9996167817520385,0,0,5
69,miRNAs involved in DNA damage response WP1545,0.13374933483482204,2.166779317336938,4.359100339819552,"['RAD52', 'CDKN1B', 'E2F1', 'ABL1', 'ATM']",0.9996167817520385,0,0,5
70,SREBF and miR33 in cholesterol and lipid homeostasis WP2011,0.13374933483482204,2.166779317336938,4.359100339819552,"['PRKAA1', 'HMGCS1', 'PPARA', 'SIRT1', 'PPARGC1A']",0.9996167817520385,0,0,5
71,TCA Cycle and Deficiency of Pyruvate Dehydrogenase complex (PDHc) WP2453,0.13374933483482204,2.166779317336938,4.359100339819552,"['ACLY', 'MDH1', 'OGDH', 'ACO1', 'IDH3A']",0.9996167817520385,0,0,5
72,Computational Model of Aerobic Glycolysis WP4629,0.13476311753945308,2.4760617760617762,4.962613949159563,"['LDHA', 'PKM', 'ENO1', 'GAPDH']",0.9996167817520385,0,0,4
73,Development of ureteric collection system WP5053,0.14116658743101015,1.6056069610571981,3.1434807740624215,"['ITGB1', 'TGFB2', 'SALL1', 'ILK', 'RARB', 'GFRA1', 'SPRY1', 'SLIT2', 'FAT4', 'PAX2']",0.9996167817520385,0,0,10
74,G13 Signaling Pathway WP524,0.14116658743101015,1.6056069610571981,3.1434807740624215,"['ROCK1', 'RPS6KB1', 'CFL2', 'ARHGDIB', 'CFL1', 'PIK3CB', 'CALM1', 'CALM2', 'MAP3K4', 'CIT']",0.9996167817520385,0,0,10
75,Ectoderm Differentiation WP2858,0.1436944168355237,1.283993324757501,2.4910322295959646,"['NLGN1', 'CTNND2', 'STC1', 'PRKAG2', 'LDB2', 'JAKMIP1', 'CELSR2', 'WDR44', 'CDH6', 'SOCS2', 'MECP2', 'TRPM2', 'NARS2', 'PLXNA2', 'DMD', 'FYN', 'CDON', 'RAB8B', 'SMAD4', 'KCNK10', 'TSC22D1', 'C1GALT1', 'PTPN13', 'AHI1', 'PPFIBP2', 'GLB1', 'TRIM33', 'ASTN1', 'BMPR1A']",0.9996167817520385,0,0,29
76,Parkin-Ubiquitin Proteasomal System pathway WP2359,0.14676701922276425,1.415999778473126,2.7171745103866773,"['PRKN', 'PSMD12', 'HSPA5', 'CUL1', 'CASK', 'UBE2L6', 'UBE2G1', 'HSPA2', 'TUBA4A', 'PSMC6', 'PSMC3', 'TUBB3', 'PSMD2', 'RNF19A', 'PSMD3', 'STUB1']",0.9996167817520385,0,0,16
77,Androgen receptor signaling pathway WP138,0.1476707193625079,1.3554050611413044,2.5925786173777152,"['RB1', 'PIAS4', 'CREBBP', 'SMAD4', 'ROCK1', 'HDAC1', 'PTEN', 'RNF6', 'SIRT1', 'PIAS2', 'PTK2', 'RHOB', 'NCOR1', 'KAT5', 'SP1', 'PRDX1', 'ZNF318', 'EP300', 'STUB1', 'RAD9A']",0.9996167817520385,0,0,20
78,Sphingolipid Metabolism (integrated pathway) WP4726,0.14801354187628502,1.7846386440947701,3.409465592843033,"['UGT8', 'CERS5', 'CERS6', 'CERK', 'SGMS1', 'DEGS1', 'SGPP2']",0.9996167817520385,0,0,7
79,T-Cell Receptor and Co-stimulatory Signaling WP2583,0.14801354187628502,1.7846386440947701,3.409465592843033,"['GSK3A', 'RASA1', 'PTEN', 'FYN', 'PTPN6', 'CALM1', 'CALM2']",0.9996167817520385,0,0,7
80,Integrated Cancer Pathway WP1971,0.1499735310286193,1.5383153272232721,2.918640225113571,"['ATF1', 'RB1', 'SMAD2', 'BARD1', 'MRE11', 'CDKN1B', 'POU2F1', 'PTEN', 'E2F1', 'ATM', 'CDC25B']",0.9996167817520385,0,0,11
81,Glycolysis and Gluconeogenesis WP534,0.16116096828240647,1.5481429538640101,2.8259052340757598,"['LDHB', 'LDHA', 'PKM', 'MDH1', 'PGAM1', 'GOT2', 'ALDOC', 'ENO1', 'ENO2', 'GAPDH']",0.9996167817520385,0,0,10
82,miRNA regulation of DNA damage response WP1530,0.16180603529117182,1.3875712347354139,2.5272625454723903,"['RB1', 'CDKN1B', 'MRE11', 'APAF1', 'SMC1A', 'CCNB3', 'RAD52', 'PIDD1', 'RRM2B', 'CCNE2', 'CCNG1', 'TLK2', 'E2F1', 'ABL1', 'ATM', 'RAD9A']",0.9996167817520385,0,0,16
83,Sulindac Metabolic Pathway WP2542,0.16208398055062884,4.331870357866307,7.882447521975214,"['MSRA', 'MSRB3']",0.9996167817520385,0,0,2
84,Vitamin B6-dependent and responsive disorders WP4228,0.16208398055062884,4.331870357866307,7.882447521975214,"['PNPO', 'AASS']",0.9996167817520385,0,0,2
85,Genotoxicity pathway WP4286,0.16366411982273624,1.445159832825031,2.6156511443129324,"['IKBIP', 'AMER1', 'TIGAR', 'ITPR1', 'CBLB', 'AEN', 'SMAD5', 'ITPKC', 'RRM2B', 'LRRFIP2', 'TRIM22', 'PHLDA3', 'DCP1B']",0.9996167817520385,0,0,13
86,The Overlap Between Signal Transduction Pathways that Contribute to a Range of LMNA Laminopathies WP4879,0.16366411982273624,1.445159832825031,2.6156511443129324,"['RB1', 'SMAD2', 'CEBPA', 'TGFB2', 'CREBBP', 'MAOA', 'HDAC1', 'DICER1', 'LEMD3', 'APC', 'CTSK', 'E2F1', 'EMD']",0.9996167817520385,0,0,13
87,Parkinson's disease pathway WP2371,0.1734608763778423,1.5603654822335025,2.733453247137987,"['PRKN', 'ATXN2', 'PINK1', 'APAF1', 'CCNE2', 'LRRK2', 'HTRA2', 'UBE2L6', 'UBE2G1']",0.9996167817520385,0,0,9
88,MAPK and NFkB signaling pathways inhibited by Yersinia YopJ WP3849,0.1735525729871825,2.166385135135135,3.7939355017939076,"['MAP3K1', 'RAF1', 'MAP3K14', 'MAP2K6']",0.9996167817520385,0,0,4
89,MAPK Signaling Pathway WP382,0.18072724559739958,1.1750007107455247,2.0101516356673175,"['LRRK2', 'ARRB2', 'PPP3CC', 'AKT3', 'RAC3', 'MAP3K8', 'PRKACA', 'MAP3K7', 'MAP3K4', 'DUSP3', 'CACNA2D3', 'CACNA2D2', 'RRAS2', 'CDC25B', 'PPM1B', 'CACNB4', 'RASA1', 'MAPKAPK2', 'RAF1', 'CACNA1B', 'CACNA1A', 'CACNA1D', 'CACNA1C', 'RASGRP2', 'CACNA1E', 'RASGRP3', 'CACNA1I', 'MAPK9', 'CACNG7', 'MAPK8', 'PPP3R2', 'MKNK1', 'FLNB', 'CD14', 'CACNG2', 'PAK2', 'MAP4K3', 'MAP4K4', 'MAP2K6', 'TGFB2', 'MAP3K1', 'NFATC3', 'HSPA2', 'TAOK3', 'TAOK1', 'NF1', 'KRAS', 'MAP3K14', 'MAP3K12']",0.9996167817520385,0,0,49
90,Leptin signaling pathway WP2034,0.18106801055243388,1.340198044236049,2.2902410773172153,"['STAT5B', 'GSK3A', 'PRKAA1', 'CISH', 'ROCK1', 'RPS6', 'PTEN', 'ACACA', 'PTK2', 'SOCS2', 'MAPK8', 'RPS6KB1', 'SP1', 'CFL2', 'FYN', 'RAF1', 'SOCS7']",0.9996167817520385,0,0,17
91,Ciliary landscape WP4352,0.1812724977401958,1.183593385032234,2.021286180820983,"['RB1', 'YAP1', 'PSMD12', 'WDR26', 'HDAC1', 'IFT172', 'SSNA1', 'VPS4A', 'HTRA2', 'IQGAP3', 'EHBP1', 'EXOSC4', 'MAEA', 'STOM', 'NEFM', 'TMED1', 'NINL', 'CEP290', 'CDR2', 'RAB8A', 'IQCB1', 'CREBBP', 'RNGTT', 'DYNLT1', 'NEK7', 'RANBP9', 'ARMC8', 'DYNLL2', 'MYL6', 'COPS6', 'PSMC6', 'RABEP2', 'APC', 'WDR60', 'VAPB', 'GLB1', 'GID8', 'EXOC4', 'MCM3', 'CD2BP2', 'EXOC3', 'CALM1', 'IFT46', 'CALM2', 'EXOC2']",0.9996167817520385,0,0,45
92,"GPCRs, Other WP117",0.18658462490455535,1.3793990755007703,2.315832263815087,"['CHRM3', 'ADGRV1', 'P2RY11', 'GPR55', 'OR2M4', 'CELSR2', 'GRM1', 'GPR176', 'ADORA2A', 'S1PR1', 'DRD3', 'ADGRL2', 'GPR135', 'ADGRL3']",0.9996167817520385,0,0,14
93,Effect of progerin on genes involved in Hutchinson-Gilford progeria syndrome WP4320,0.1871015597598034,1.7333333333333334,2.9052464293378053,"['RB1', 'MBD3', 'HDAC1', 'MBD2', 'E2F1', 'CHD3']",0.9996167817520385,0,0,6
94,16p11.2 proximal deletion syndrome WP4949,0.19417918457020517,1.3339943638451102,2.1863819642974462,"['KMT2D', 'PAXIP1', 'KMT2C', 'PTEN', 'MSN', 'PPP4R3A', 'PPP4R3B', 'TBX6', 'HIRA', 'PPP4R1', 'PPP4R4', 'TCP1', 'TMEM219', 'EZR', 'BPTF', 'MAP2K6']",0.9996167817520385,0,0,16
95,Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling WP3850,0.19703486524187067,1.5002342834830145,2.436942441605824,"['ITGB1', 'RPTOR', 'SMAD2', 'RPS6KB1', 'JKAMP', 'PTEN', 'ILK', 'IGF1', 'PPARGC1A']",0.9996167817520385,0,0,9
96,Neural Crest Cell Migration in Cancer WP4565,0.19703486524187067,1.5002342834830145,2.436942441605824,"['TIAM1', 'TRIO', 'SORT1', 'KIDINS220', 'AKT3', 'PIK3R4', 'PIK3CB', 'PAK2', 'PAK5']",0.9996167817520385,0,0,9
97,DNA IR-double strand breaks and cellular response via ATM WP3959,0.20078753897926013,1.3744493392070485,2.206689340922934,"['YAP1', 'MRE11', 'DCLRE1C', 'APAF1', 'SMC3', 'SMC1A', 'LATS1', 'RAD52', 'KAT5', 'E2F1', 'ABL1', 'ATM', 'RAD9A']",0.9996167817520385,0,0,13
98,15q13.3 copy number variation syndrome WP4942,0.20099572421227097,1.8053678044384365,2.8966614487156988,"['CREBBP', 'KLF13', 'OTUD7A', 'FYN', 'FAN1']",0.9996167817520385,0,0,5
99,BMP Signaling Pathway in Eyelid Development WP3927,0.20099572421227097,1.8053678044384365,2.8966614487156988,"['MAPK9', 'SMAD4', 'MAP3K1', 'INHBB', 'SMAD5']",0.9996167817520385,0,0,5
100,Mitochondrial Gene Expression WP391,0.20099572421227097,1.8053678044384365,2.8966614487156988,"['MYEF2', 'SP1', 'NRF1', 'PPARGC1A', 'HCFC1']",0.9996167817520385,0,0,5
101,7-oxo-C and 7beta-HC pathways WP5064,0.2021505782433735,1.5965327590196323,2.5524446506480487,"['HSD11B1', 'ACOT9', 'EBP', 'AMACR', 'SCP2', 'ACOT11', 'ACOT4']",0.9996167817520385,0,0,7
102,Signal transduction through IL1R WP4496,0.2021505782433735,1.5965327590196323,2.5524446506480487,"['MAPK8', 'TGFB2', 'MAP3K1', 'TOLLIP', 'MAP3K7', 'MAP3K14', 'MAP2K6']",0.9996167817520385,0,0,7
103,Common Pathways Underlying Drug Addiction WP2636,0.20493649679311707,1.4447077409162716,2.289941401027232,"['GRIA1', 'GRIN2A', 'GJB1', 'PPP1R1A', 'PRKACA', 'RAF1', 'CALM1', 'CALM2', 'GRM1', 'GRIA3']",0.9996167817520385,0,0,10
104,DNA damage response WP707,0.2084812715620639,1.3270496397948803,2.0806891806750483,"['RB1', 'CDKN1B', 'MRE11', 'APAF1', 'SMC1A', 'CCNB3', 'RAD52', 'PIDD1', 'RRM2B', 'CCNE2', 'TLK2', 'E2F1', 'ABL1', 'ATM', 'RAD9A']",0.9996167817520385,0,0,15
105,Sterol regulatory element-binding proteins (SREBP) signaling WP1982,0.2084812715620639,1.3270496397948803,2.0806891806750483,"['GSK3A', 'PRKAA1', 'HMGCS1', 'MDH1', 'SAR1B', 'PRKAG2', 'SIRT1', 'ACACA', 'ACLY', 'GPAM', 'SP1', 'PRKACA', 'SEC24D', 'LPIN1', 'ATF6']",0.9996167817520385,0,0,15
106,Neovascularisation processes WP4331,0.21332882862105051,1.5073248220274167,2.328697028800352,"['DLL4', 'SMAD2', 'MAPK9', 'MAPK8', 'TGFB2', 'NOTCH4', 'KIT', 'SMAD5']",0.9996167817520385,0,0,8
107,Wnt signaling in kidney disease WP4150,0.21332882862105051,1.5073248220274167,2.328697028800352,"['INVS', 'FZD1', 'MAPK9', 'MAPK8', 'FZD6', 'DVL2', 'FZD9', 'LRP6']",0.9996167817520385,0,0,8
108,Cell-type Dependent Selectivity of CCK2R Signaling WP3679,0.21557346812816025,1.9255255255255255,2.9546293976748803,"['GNAQ', 'ITPR1', 'CCK', 'RYR3']",0.9996167817520385,0,0,4
109,Cori Cycle WP1946,0.21557346812816025,1.9255255255255255,2.9546293976748803,"['G6PD', 'LDHA', 'PGAM1', 'GAPDH']",0.9996167817520385,0,0,4
110,Regulation of sister chromatid separation at the metaphase-anaphase transition WP4240,0.21557346812816025,1.9255255255255255,2.9546293976748803,"['SMC1A', 'SMC3', 'MAD1L1', 'ANAPC11']",0.9996167817520385,0,0,4
111,1q21.1 copy number variation syndrome WP4905,0.21905462658501632,1.6248732251521298,2.467262984431192,"['PYGO1', 'PYGO2', 'PRKAA1', 'PRKAG2', 'CHD1L', 'TJP2']",0.9996167817520385,0,0,6
112,Constitutive Androstane Receptor Pathway WP2875,0.21905462658501632,1.6248732251521298,2.467262984431192,"['RXRA', 'NCOA6', 'SP1', 'SMC1A', 'CYP3A5', 'PPARGC1A']",0.9996167817520385,0,0,6
113,Phosphoinositides metabolism WP4971,0.2218646811339605,1.444557247602933,2.1750519747856014,"['PIKFYVE', 'PIP4P1', 'PTEN', 'PIK3R4', 'PIP5K1B', 'PLCH1', 'PIK3CB', 'PIP4K2C', 'SBF2']",0.9996167817520385,0,0,9
114,EGF/EGFR signaling pathway WP437,0.22450177400755833,1.1828417232716106,1.7670137402445045,"['ATF1', 'SH3GL3', 'ROCK1', 'INPPL1', 'PTEN', 'CBLB', 'CBL', 'MAPK9', 'ATXN2', 'MAPK8', 'RPS6KA2', 'CFL1', 'ABL1', 'REPS2', 'E2F1', 'CSK', 'MAP3K4', 'SH3GL2', 'STAT5B', 'MAP3K1', 'CAV2', 'PTPN12', 'PTK2', 'EPN1', 'ITCH', 'RPS6KB1', 'SP1', 'RASA1', 'NEDD4', 'KRAS', 'RAF1', 'STAM2', 'ARF6']",0.9996167817520385,0,0,33
115,Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms WP4534,0.2285124416723712,1.397995064101164,2.063670853676578,"['ITGB1', 'LATS1', 'MAPK9', 'MAPK8', 'SGMS1', 'MAP4K5', 'PAK2', 'PAK5', 'MAP4K3', 'MAP4K4']",0.9996167817520385,0,0,10
116,Estrogen Receptor Pathway WP2881,0.2296261585237609,2.1659912191827084,3.186828707676207,"['GPAM', 'SP1', 'PPARA']",0.9996167817520385,0,0,3
117,Leptin and adiponectin WP3934,0.2296261585237609,2.1659912191827084,3.186828707676207,"['PRKAA1', 'ADIPOR1', 'ACACA']",0.9996167817520385,0,0,3
118,NLR Proteins WP288,0.2296261585237609,2.1659912191827084,3.186828707676207,"['MAPK8', 'ERBIN', 'MAP3K7']",0.9996167817520385,0,0,3
119,Intraflagellar transport proteins binding to dynein WP4532,0.23169668250067957,1.5165877578626987,2.217745960944031,"['DYNC2H1', 'DYNLT1', 'WDR60', 'WDR19', 'IFT46', 'DYNLL2', 'DYNC1I1']",0.9996167817520385,0,0,7
120,Nanoparticle-mediated activation of receptor signaling WP2643,0.23169668250067957,1.5165877578626987,2.217745960944031,"['ITGB1', 'MAPK9', 'MAPK8', 'AKT3', 'KRAS', 'RAF1', 'PTK2']",0.9996167817520385,0,0,7
121,Proximal tubule transport WP4917,0.23376245496307427,1.3620821440665667,1.979718059334401,"['ATP6V1A', 'ATP6V0B', 'SLC22A6', 'SLC7A8', 'SLC3A1', 'ATP1A1', 'SLC5A2', 'SLC22A8', 'ATP6V0C', 'ATP6V1C1', 'AQP1']",0.9996167817520385,0,0,11
122,miR-517 relationship with ARCN1 and USP1 WP3596,0.23758524264792052,2.8876884987620977,4.150269085928353,"['USP1', 'ARCN1']",0.9996167817520385,0,0,2
123,Somatroph axis (GH) and its relationship to dietary restriction and aging WP4186,0.23758524264792052,2.8876884987620977,4.150269085928353,"['PTEN', 'SIRT1']",0.9996167817520385,0,0,2
124,Methionine De Novo and Salvage Pathway WP3580,0.23814855257974743,1.6663633764005512,2.3909992032726866,"['MSRA', 'AHCY', 'MSRB3', 'MAT2B', 'ENOPH1']",0.9996167817520385,0,0,5
125,Melatonin metabolism and effects WP3298,0.24090868691647968,1.4444068561118628,2.0558781687657586,"['PER1', 'PER3', 'MAOA', 'MAP2', 'CALM1', 'SIRT1', 'CALM2', 'ARNTL']",0.9996167817520385,0,0,8
126,Mitochondrial CIV Assembly WP4922,0.24090868691647968,1.4444068561118628,2.0558781687657586,"['COX8A', 'SURF1', 'SCO2', 'COX17', 'COX6A1', 'HIGD1A', 'COX5B', 'COX5A']",0.9996167817520385,0,0,8
127,Kit receptor signaling pathway WP304,0.24130451636078043,1.3103165659256224,1.8628712829383924,"['GRB7', 'STAT5B', 'RPS6', 'MITF', 'FOXO3', 'CBL', 'MAPK8', 'RPS6KB1', 'KIT', 'EP300', 'FYN', 'PTPN6', 'RAF1']",0.9996167817520385,0,0,13
128,Vitamin D-sensitive calcium signaling in depression WP4698,0.24780335366653775,1.3928571428571428,1.9432025453036035,"['GRIN2A', 'G6PD', 'CHRM1', 'RXRA', 'ITPR1', 'ATP2B4', 'KCNQ3', 'CACNA1C', 'GRIN2B']",0.9996167817520385,0,0,9
129,EPO Receptor Signaling WP581,0.2526518493640303,1.5291731296981268,2.103748965043362,"['STAT5B', 'CISH', 'RASA1', 'IRS2', 'RAF1', 'EPOR']",0.9996167817520385,0,0,6
130,Sphingolipid Metabolism (general overview) WP4725,0.2526518493640303,1.5291731296981268,2.103748965043362,"['UGT8', 'CERS6', 'CERK', 'SGMS1', 'DEGS1', 'SGPP2']",0.9996167817520385,0,0,6
131,Airway smooth muscle cell contraction WP4962,0.2599563146748626,1.7328378378378377,2.334551364260823,"['ROCK1', 'GNAQ', 'CALM1', 'CALM2']",0.9996167817520385,0,0,4
132,ID signaling pathway WP53,0.2599563146748626,1.7328378378378377,2.334551364260823,"['RB1', 'RBL1', 'ID3', 'PAX2']",0.9996167817520385,0,0,4
133,Glycerophospholipid Biosynthetic Pathway WP2533,0.26256151163228275,1.4442565663397589,1.9313608259177026,"['GPAM', 'AGPS', 'CHPT1', 'PIK3CB', 'CEPT1', 'LPIN1', 'PI4K2A']",0.9996167817520385,0,0,7
134,PI3K-AKT-mTOR signaling pathway and therapeutic opportunities WP3844,0.26256151163228275,1.4442565663397589,1.9313608259177026,"['RPTOR', 'CDKN1B', 'PTEN', 'TFEB', 'KRAS', 'PIK3CB', 'FOXO3']",0.9996167817520385,0,0,7
135,Type I collagen synthesis in the context of Osteogenesis imperfecta WP4786,0.26256151163228275,1.4442565663397589,1.9313608259177026,"['FZD1', 'BMP1', 'P4HA1', 'SERPINF1', 'ITPR1', 'P3H2', 'LRP6']",0.9996167817520385,0,0,7
136,Pyrimidine metabolism WP4022,0.268254333438551,1.2190364052953158,1.6040321696750408,"['PNPT1', 'DPYS', 'NME3', 'CTPS1', 'DCTD', 'POLA1', 'RRM2B', 'NME6', 'NME7', 'POLR2C', 'POLR1C', 'DPYD', 'CMPK1', 'CMPK2', 'POLR3H', 'TK1', 'ENPP3', 'POLR2J']",0.9996167817520385,0,0,18
137,Retinoblastoma gene in cancer WP2446,0.268254333438551,1.2190364052953158,1.6040321696750408,"['RB1', 'BARD1', 'DNMT1', 'CDKN1B', 'HDAC1', 'FAF1', 'SMC3', 'SMC1A', 'SMARCA2', 'CDC25B', 'POLA1', 'CCNE2', 'MCM3', 'E2F1', 'ABL1', 'ZNF655', 'SKP2', 'RAF1']",0.9996167817520385,0,0,18
138,Genes related to primary cilium development (based on CRISPR) WP4536,0.26847873069052974,1.1920717199184228,1.567554742018971,"['DYNC2H1', 'C2CD3', 'DYNLT1', 'IFT172', 'CEP295', 'CEP120', 'WDR19', 'ARMC9', 'SCLT1', 'CPLANE1', 'TTBK2', 'MIB1', 'ICK', 'WDR60', 'CDK20', 'CEP162', 'WDPCP', 'CEP192', 'KIFAP3', 'IFT46', 'PIBF1', 'CEP44']",0.9996167817520385,0,0,22
139,Fas ligand pathway and stress induction of heat shock proteins WP314,0.2746923679926002,1.3447225625765797,1.7375206883913146,"['RB1', 'MAPK8', 'MAP3K1', 'APAF1', 'FAF1', 'ARHGDIB', 'MAPKAPK2', 'PAK2', 'MAP3K7']",0.9996167817520385,0,0,9
140,Thymic Stromal LymphoPoietin (TSLP) Signaling Pathway WP2203,0.2746923679926002,1.3447225625765797,1.7375206883913146,"['MAPK9', 'STAT5B', 'HCK', 'MAPK8', 'YES1', 'CISH', 'RPS6', 'FYN', 'PI4K2A']",0.9996167817520385,0,0,9
141,Hereditary leiomyomatosis and renal cell carcinoma pathway WP4206,0.2769586693508927,1.5472167237966494,1.9864514255600298,"['EGLN1', 'PRKAA1', 'LDHA', 'RPS6', 'ACACA']",0.9996167817520385,0,0,5
142,Serotonin Receptor 2 and ELK-SRF/GATA4 signaling WP732,0.2769586693508927,1.5472167237966494,1.9864514255600298,"['GNAQ', 'MAPKAPK2', 'ITPR1', 'KRAS', 'RAF1']",0.9996167817520385,0,0,5
143,Dopamine metabolism WP2436,0.2851621557917437,1.8564191634100449,2.329244098677,"['MAOA', 'COMT', 'PRKACA']",0.9996167817520385,0,0,3
144,MTHFR deficiency WP4288,0.28753128221254065,1.4441063781834573,1.799968295182079,"['DNMT1', 'GRIN2A', 'SGMS1', 'EHMT1', 'CHPT1', 'COMT']",0.9996167817520385,0,0,6
145,Physiological and pathological hypertrophy of the heart WP1528,0.28753128221254065,1.4441063781834573,1.799968295182079,"['MAPK8', 'MYEF2', 'PRKCE', 'LIFR', 'CALM1', 'CALM2']",0.9996167817520385,0,0,6
146,Sphingolipid pathway WP1422,0.29447777512132955,1.3785009376825406,1.6852887271502148,"['UGT8', 'CERS5', 'CERS6', 'CERK', 'SGMS1', 'SERINC1', 'SGPP2']",0.9996167817520385,0,0,7
147,Gastrin signaling pathway WP4659,0.3016296178779604,1.16281441196465,1.3936975451669824,"['ITGB1', 'YES1', 'CDKN1B', 'ROCK1', 'PRKCE', 'ARHGEF28', 'RPS6', 'ARRB2', 'FOXO3', 'PTK2', 'RHOB', 'MAPK9', 'MAPK8', 'KAT5', 'RPS6KB1', 'SP1', 'GNAQ', 'KIT', 'FYN', 'KRAS', 'PRKACA', 'RAF1']",0.9996167817520385,0,0,22
148,DNA damage response (only ATM dependent) WP710,0.3026726987609902,1.1668496301523825,1.3945057962487053,"['SMAD4', 'CDKN1B', 'MAP3K1', 'INSR', 'PIK3R4', 'PTEN', 'PIK3CB', 'PPP2R5C', 'FOXO3', 'MAPK9', 'MAPK8', 'SCP2', 'APC', 'AKT3', 'DVL2', 'ABL1', 'RAC3', 'ATM', 'KRAS', 'MAP3K7', 'MAP3K4']",0.9996167817520385,0,0,21
149,Blood Clotting Cascade WP272,0.3058497567057217,1.5751842751842753,1.866059833479262,"['F8A1', 'F11', 'PLG', 'F5']",0.9996167817520385,0,0,4
150,MAP3K1 role in promoting and blocking gonadal determination WP4872,0.3058497567057217,1.5751842751842753,1.866059833479262,"['MAP3K1', 'ROCK1', 'SOX9', 'MAP3K4']",0.9996167817520385,0,0,4
151,Regulation of Wnt/B-catenin Signaling by Small Molecule Compounds WP3664,0.3058497567057217,1.5751842751842753,1.866059833479262,"['FZD1', 'APC', 'TNKS', 'DVL2']",0.9996167817520385,0,0,4
152,Wnt Signaling Pathway WP363,0.3059111790896563,1.2542552622667404,1.4856157944741033,"['MAPK9', 'GSK3A', 'MAPK8', 'APC', 'DVL2', 'PIP5K1B', 'ARRB2', 'MAP3K7', 'PI4K2A', 'CSNK1G1', 'LRP6']",0.9996167817520385,0,0,11
153,Melanoma WP4685,0.3072220307765194,1.2133016949152542,1.4319199336493638,"['RB1', 'PTEN', 'MITF', 'PIK3CB', 'GRM3', 'GRIN2A', 'AKT3', 'KIT', 'E2F1', 'NF1', 'KRAS', 'RAF1', 'CALM1', 'CALM2']",0.9996167817520385,0,0,14
154,Primary focal segmental glomerulosclerosis (FSGS) WP2572,0.3072220307765194,1.2133016949152542,1.4319199336493638,"['ITGB1', 'SMARCAL1', 'CDKN1B', 'KIRREL2', 'PTPRO', 'ILK', 'PAX2', 'PTK2', 'LRP6', 'CDH2', 'MYH9', 'COL4A5', 'FYN', 'UTRN']",0.9996167817520385,0,0,14
155,Calcium Regulation in the Cardiac Cell WP536,0.30937622948152554,1.1342534823906898,1.330702977401625,"['YWHAE', 'CHRM3', 'CHRM1', 'RGS14', 'CACNA1B', 'ITPR1', 'GNAI3', 'CACNA1A', 'ATP2A2', 'CACNA1D', 'CACNA1C', 'ARRB2', 'CACNA1E', 'ADRA1A', 'RYR3', 'ADCY5', 'RGS1', 'PRKAR2A', 'PRKACA', 'RGS6', 'YWHAG', 'KCNJ3', 'PRKCE', 'GJB1', 'GNAQ', 'CASQ1', 'CALM1', 'CALM2']",0.9996167817520385,0,0,28
156,Arachidonate Epoxygenase / Epoxide Hydrolase WP678,0.3142602461366494,2.1655975692099934,2.506752442017218,"['COX8A', 'COX5A']",0.9996167817520385,0,0,2
157,exRNA mechanism of action and biogenesis WP2805,0.3142602461366494,2.1655975692099934,2.506752442017218,"['DROSHA', 'DICER1']",0.9996167817520385,0,0,2
158,miRNA Biogenesis WP2338,0.3142602461366494,2.1655975692099934,2.506752442017218,"['DROSHA', 'DICER1']",0.9996167817520385,0,0,2
159,Molybdenum cofactor (Moco) biosynthesis WP4507,0.3142602461366494,2.1655975692099934,2.506752442017218,"['SUOX', 'GPHN']",0.9996167817520385,0,0,2
160,Pilocytic astrocytoma WP2253,0.3142602461366494,2.1655975692099934,2.506752442017218,"['NF1', 'RAF1']",0.9996167817520385,0,0,2
161,One-carbon metabolism WP241,0.316898803683147,1.4439562915399347,1.6593552763655082,"['AHCYL2', 'DNMT1', 'ALDH1L1', 'AHCY', 'MAT2B']",0.9996167817520385,0,0,5
162,Host-pathogen interaction of human coronaviruses - MAPK signaling WP4877,0.32943262555826747,1.2836164987721144,1.4253064788154117,"['MAPK9', 'MAPK8', 'MAP3K1', 'RPS6KA2', 'MAP3K10', 'RAF1', 'MAP3K4', 'MAP2K6']",0.9996167817520385,0,0,8
163,Aryl Hydrocarbon Receptor Netpath WP2586,0.33065100217694804,1.2577697723923367,1.3919635360784293,"['RB1', 'CDKN1B', 'E2F1', 'AIP', 'NF1', 'EP300', 'ARNT', 'KRAS', 'RAF1']",0.9996167817520385,0,0,9
164,Ebola Virus Pathway on Host WP4217,0.33403406610291375,1.1326350035547588,1.2419482092817673,"['ITGB1', 'VPS18', 'CREBBP', 'TSG101', 'GSN', 'CAV3', 'CAV2', 'DDX58', 'ACTN1', 'CLTC', 'VPS4A', 'PIK3CB', 'RHOB', 'TIAM1', 'NEDD4', 'VPS11', 'EP300', 'RAB9A', 'FLNB', 'TOP1', 'IKBKE', 'HLA-DRB1', 'CTSB']",0.9996167817520385,0,0,23
165,"COVID-19, thrombosis and anticoagulation WP4927",0.3400651539501913,4.330745865676679,4.67122066269642,['PLG'],0.9996167817520385,0,0,1
166,Biogenic Amine Synthesis WP550,0.34156178465085385,1.624240121580547,1.744802097621718,"['MAOA', 'GAD2', 'COMT']",0.9996167817520385,0,0,3
167,Farnesoid X receptor pathway WP2879,0.34156178465085385,1.624240121580547,1.744802097621718,"['RXRA', 'IRS2', 'PPARGC1A']",0.9996167817520385,0,0,3
168,"NAD metabolism, sirtuins and aging WP3630",0.34156178465085385,1.624240121580547,1.744802097621718,"['FOXO3', 'ROS1', 'SIRT1']",0.9996167817520385,0,0,3
169,Pathogenesis of SARS-CoV-2 Mediated by nsp9-nsp10 Complex WP4884,0.34156178465085385,1.624240121580547,1.744802097621718,"['NKRF', 'FYN', 'HLA-DRB1']",0.9996167817520385,0,0,3
170,"4-hydroxytamoxifen, Dexamethasone, and Retinoic Acids Regulation of p27 Expression WP3879",0.352457105806631,1.4438063063063062,1.5056392602078328,"['PRKAA1', 'MKNK1', 'RAF1', 'MAP2K6']",0.9996167817520385,0,0,4
171,Deregulation of Rab and Rab Effector Genes in Bladder Cancer WP2291,0.352457105806631,1.4438063063063062,1.5056392602078328,"['MADD', 'MYRIP', 'SYTL5', 'SYTL3']",0.9996167817520385,0,0,4
172,Transcription co-factors SKI and SKIL protein partners WP4533,0.352457105806631,1.4438063063063062,1.5056392602078328,"['LATS1', 'MECP2', 'HDAC1', 'NF1']",0.9996167817520385,0,0,4
173,Integrated breast cancer pathway WP1984,0.3526942058339305,1.1023969634478017,1.1488672616283786,"['ATF1', 'RB1', 'GSK3A', 'USP15', 'MRE11', 'CERK', 'HDAC1', 'MYCBP2', 'PTEN', 'JAKMIP1', 'RASGRP3', 'ABL1', 'E2F1', 'EP300', 'SMAD2', 'BARD1', 'SMAD4', 'PPP4R3A', 'PPP4R3B', 'MYT1', 'SIRT1', 'CDC25B', 'ITPKC', 'SP1', 'NF1', 'ATM', 'KRAS', 'ZNF655', 'BMPR1A']",0.9996167817520385,0,0,29
174,IL-2 signaling pathway WP49,0.36016631739068133,1.2376763966750435,1.2639019692219822,"['STAT5B', 'CISH', 'RPS6KB1', 'RPS6', 'FYN', 'FOXO3', 'CBL', 'RAF1']",0.9996167817520385,0,0,8
175,G Protein Signaling Pathways WP35,0.36353864022458277,1.1302576817497565,1.1436734868624043,"['PDE1C', 'PRKCE', 'PDE1A', 'ITPR1', 'GNAI3', 'AKAP6', 'AKAP3', 'ADCY5', 'AKAP13', 'PPP3CC', 'PRKAR2A', 'GNAQ', 'AKAP9', 'KRAS', 'PRKACA', 'CALM1', 'CALM2', 'KCNJ3']",0.9996167817520385,0,0,18
176,Arrhythmogenic Right Ventricular Cardiomyopathy WP2118,0.3742412171231077,1.144355612408059,1.1247353194752547,"['ITGB1', 'ACTN1', 'ITGA2B', 'CACNA2D3', 'ATP2A2', 'CACNA2D2', 'CACNA1D', 'CACNA1C', 'CACNG7', 'CACNB4', 'CDH2', 'DMD', 'CACNG2', 'EMD']",0.9996167817520385,0,0,14
177,Structural Pathway of Interleukin 1 (IL-1) WP2637,0.38553300035034144,1.1707442039195595,1.1158696501313312,"['MAPK9', 'MAPK8', 'MAP3K1', 'MKNK1', 'TOLLIP', 'MAPKAPK2', 'MAP3K8', 'MAP3K7', 'MAP3K14', 'MAP2K6']",0.9996167817520385,0,0,10
178,Benzo(a)pyrene metabolism WP696,0.3890114582264666,1.7323430114787306,1.635585556790988,"['AKR1C1', 'EPHX1']",0.9996167817520385,0,0,2
179,Folate-Alcohol and Cancer Pathway Hypotheses WP1589,0.3890114582264666,1.7323430114787306,1.635585556790988,"['ALDH1L1', 'ALDH1A1']",0.9996167817520385,0,0,2
180,LDLRAD4 and what we know about it WP4904,0.3890114582264666,1.7323430114787306,1.635585556790988,"['SMAD2', 'NEDD4']",0.9996167817520385,0,0,2
181,Hedgehog Signaling Pathway WP4249,0.39116298894931106,1.1949045774812188,1.1215744238854835,"['SUFU', 'SPOP', 'FBXL17', 'SPOPL', 'ARRB2', 'PRKACA', 'CDON', 'CSNK1G1']",0.9996167817520385,0,0,8
182,Initiation of transcription and translation elongation at the HIV-1 LTR WP3414,0.393829351424516,1.212796753466351,1.1301295938665885,"['CREBBP', 'PPP3CC', 'PPP3R2', 'HDAC1', 'SP1', 'NFATC3', 'EP300']",0.9996167817520385,0,0,7
183,Neural Crest Cell Migration during Development WP4564,0.393829351424516,1.212796753466351,1.1301295938665885,"['TIAM1', 'TRIO', 'AKT3', 'PIK3R4', 'PIK3CB', 'PAK2', 'PAK5']",0.9996167817520385,0,0,7
184,Extracellular vesicle-mediated signaling in recipient cells WP2870,0.3962465909389015,1.2375156959335458,1.1455912444732763,"['SMAD2', 'TGFB2', 'SMAD4', 'APC', 'KRAS', 'RAF1']",0.9996167817520385,0,0,6
185,Cancer immunotherapy by CTLA4 blockade WP4582,0.3975648384138283,1.4436564223798267,1.331624703384976,"['PTPN6', 'PIK3CB', 'HLA-DRB1']",0.9996167817520385,0,0,3
186,RalA downstream regulated genes WP2290,0.3975648384138283,1.4436564223798267,1.331624703384976,"['RAC3', 'KRAS', 'EXOC2']",0.9996167817520385,0,0,3
187,Follicle Stimulating Hormone (FSH) signaling pathway WP2035,0.39816801211844544,1.2738802854700515,1.1730924336762307,"['RPS6KB1', 'RPS6', 'PRKACA', 'SGK1', 'RAF1']",0.9996167817520385,0,0,5
188,NAD+ biosynthetic pathways WP3645,0.39816801211844544,1.2738802854700515,1.1730924336762307,"['BST1', 'TNKS2', 'TNKS', 'NADSYN1', 'SIRT1']",0.9996167817520385,0,0,5
189,Nanoparticle triggered autophagic cell death WP2509,0.39816801211844544,1.2738802854700515,1.1730924336762307,"['SH3GLB1', 'UVRAG', 'INSR', 'ATG10', 'AMBRA1']",0.9996167817520385,0,0,5
190,Zinc homeostasis WP3529,0.39816801211844544,1.2738802854700515,1.1730924336762307,"['SLC30A7', 'SLC39A6', 'SLC30A1', 'SLC39A12', 'SLC39A1']",0.9996167817520385,0,0,5
191,Pyrimidine metabolism and related diseases WP4225,0.399060593999332,1.3326403326403327,1.2242193924012543,"['CPS1', 'RRM2B', 'DPYS', 'DPYD']",0.9996167817520385,0,0,4
192,TGF-B Signaling in Thyroid Cells for Epithelial-Mesenchymal Transition WP3859,0.399060593999332,1.3326403326403327,1.2242193924012543,"['SMAD2', 'CDH6', 'SMAD4', 'CDH2']",0.9996167817520385,0,0,4
193,Integrin-mediated Cell Adhesion WP185,0.3996282572304396,1.0974623655913978,1.0066150026555896,"['ITGB1', 'GIT2', 'CAV3', 'ROCK1', 'CAV2', 'ITGA2B', 'ILK', 'PTK2', 'AKT3', 'CAPN2', 'CAPN3', 'RAC3', 'FYN', 'CSK', 'CAPN1', 'RAF1', 'MAPK6', 'PAK2', 'MAP2K6']",0.9996167817520385,0,0,19
194,Association Between Physico-Chemical Features and Toxicity Associated Pathways WP3680,0.4046732349892965,1.1299929303640863,1.0222767664112637,"['GRIA1', 'FZD1', 'MAPK8', 'CDKN1B', 'APC', 'FZD6', 'FZD9', 'NEFM', 'NOS1', 'RAF1', 'CBL', 'PTK2']",0.9996167817520385,0,0,12
195,Synaptic Vesicle Pathway WP2267,0.4129918548028626,1.1398460606492535,1.0079971126094383,"['NSF', 'SYT1', 'CLTC', 'CACNA1B', 'CACNA1A', 'SYN3', 'SLC25A4', 'CPLX1', 'DNM2', 'CPLX3']",0.9996167817520385,0,0,10
196,ATM Signaling Network in Development and Disease  WP3878,0.41747553528503745,1.146521349656614,1.0015200315874968,"['PRKAA1', 'G6PD', 'MRE11', 'DCLRE1C', 'KAT5', 'ATM', 'CEP63', 'SMC1A', 'LBR']",0.9996167817520385,0,0,9
197,IL-3 signaling pathway WP286,0.41747553528503745,1.146521349656614,1.0015200315874968,"['HCK', 'STAT5B', 'MAPK8', 'FYN', 'PTPN6', 'ENPP3', 'PRKACA', 'RAF1', 'CBL']",0.9996167817520385,0,0,9
198,Netrin-UNC5B signaling pathway WP4747,0.41747553528503745,1.146521349656614,1.0015200315874968,"['YAP1', 'ARHGEF12', 'PPP2R1B', 'AGAP2', 'NTN4', 'FYN', 'RAF1', 'RLF', 'PTK2']",0.9996167817520385,0,0,9
199,Spinal Cord Injury WP2431,0.4191221764391499,1.0829371816638371,0.9417143879582772,"['RB1', 'EPHA4', 'SEMA6A', 'CDKN1B', 'OMG', 'FOXO3', 'RTN4', 'AQP1', 'RHOB', 'CHST11', 'PRB1', 'CCNG1', 'PLXNA2', 'E2F1', 'SLIT3', 'SOX9', 'NOS1', 'SLIT2', 'ROS1']",0.9996167817520385,0,0,19
200,ATM Signaling Pathway WP2516,0.4222218116141849,1.1549842129003158,0.9958556659532535,"['PIDD1', 'MAPK9', 'MRE11', 'ABL1', 'MDM4', 'ATM', 'SMC1A', 'RAD9A']",0.9996167817520385,0,0,8
201,Prostaglandin Synthesis and Regulation WP98,0.4222218116141849,1.1549842129003158,0.9958556659532535,"['HSD11B1', 'CBR1', 'AKR1C1', 'ANXA4', 'ANXA5', 'MITF', 'SOX9', 'PPARGC1A']",0.9996167817520385,0,0,8
202,Disruption of postsynaptic signaling by CNV WP4875,0.42727796532922524,1.1660596758669128,0.9915244522990907,"['NLGN1', 'GRIN2A', 'DLG2', 'DLGAP1', 'GRIN2B', 'GRM1', 'YWHAG']",0.9996167817520385,0,0,7
203,Regucalcin in proximal tubule epithelial kidney cells WP4838,0.4327061456239728,1.1811727825926608,0.9894642218738038,"['SMAD2', 'SEC16B', 'SMAD4', 'APAF1', 'NOS1', 'RAF1']",0.9996167817520385,0,0,6
204,T-Cell antigen Receptor (TCR) pathway during Staphylococcus aureus infection WP3863,0.4404484294710378,1.1105324375466556,0.9105943021280082,"['MAPK9', 'MAP3K8', 'FYN', 'PTPN6', 'RAF1', 'CBL', 'CALM1', 'MAP3K7', 'MAP3K14', 'CALM2']",0.9996167817520385,0,0,10
205,Small cell lung cancer WP4658,0.44354034837932227,1.0679909605780766,0.8682408777284191,"['ITGB1', 'RB1', 'CDKN1B', 'APAF1', 'LAMA4', 'ITGA2B', 'LAMA3', 'PTEN', 'PIK3CB', 'FHIT', 'PTK2', 'RXRA', 'CCNE2', 'TRAF3', 'AKT3', 'E2F1', 'RARB', 'COL4A5']",0.9996167817520385,0,0,18
206,Nucleotide metabolism WP404,0.4450354454904095,1.2373552123552123,1.0017644468884328,"['PRPS2', 'PRPS1', 'POLA1', 'RRM2B']",0.9996167817520385,0,0,4
207,Simplified Interaction Map Between LOXL4 and Oxidative Stress Pathway WP3670,0.4450354454904095,1.2373552123552123,1.0017644468884328,"['ANXA5', 'NRF1', 'PKD1', 'SIRT1']",0.9996167817520385,0,0,4
208,Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways WP706,0.447146347468579,1.0513119514265798,0.8461687551052258,"['YWHAE', 'THRB', 'MAOA', 'HDAC1', 'ATP1A3', 'MECP2', 'DEAF1', 'MAP2', 'PRKAR2A', 'EP300', 'PRKACA', 'PPARGC1A', 'YWHAG', 'KCNH2', 'CREBBP', 'CAV3', 'SSTR1', 'ADCYAP1', 'TF', 'SP1', 'BHLHE40', 'NOS1AP', 'GAPDH', 'SLC25A4', 'CC2D1A']",0.9996167817520385,0,0,25
209,Cysteine and methionine catabolism WP4504,0.4521622273989372,1.2991894630192502,1.0311851946240473,"['MPST', 'AHCY', 'SUOX']",0.9996167817520385,0,0,3
210,FOXA2 pathway WP5066,0.4521622273989372,1.2991894630192502,1.0311851946240473,"['MLXIPL', 'IRS2', 'ACACA']",0.9996167817520385,0,0,3
211,Glutathione metabolism WP100,0.4521622273989372,1.2991894630192502,1.0311851946240473,"['GPX2', 'G6PD', 'GPX3']",0.9996167817520385,0,0,3
212,GPR40 Pathway WP3958,0.4521622273989372,1.2991894630192502,1.0311851946240473,"['PLCL1', 'PLCH1', 'PKD1']",0.9996167817520385,0,0,3
213,Homologous recombination WP186,0.4521622273989372,1.2991894630192502,1.0311851946240473,"['RAD52', 'MRE11', 'ATM']",0.9996167817520385,0,0,3
214,Ras signaling WP4223,0.45299935845166794,1.0408793811136043,0.8242355032575986,"['PIK3CB', 'RASGRP2', 'RASGRP3', 'MAPK9', 'GRIN2A', 'MAPK8', 'AKT3', 'ABL1', 'RAC3', 'SHOC2', 'PRKACA', 'PAK2', 'PAK5', 'PLA2G12A', 'KSR1', 'INSR', 'RRAS2', 'KSR2', 'GRIN2B', 'TIAM1', 'RASA1', 'KIT', 'NF1', 'KRAS', 'RAF1', 'RGL1', 'CALM1', 'RAPGEF5', 'CALM2', 'EXOC2', 'ARF6']",0.9996167817520385,0,0,31
215,Brain-derived neurotrophic factor (BDNF) signaling pathway WP2380,0.4547506570250326,1.0441503720998102,0.8227967756377678,"['GRIA1', 'GABRB3', 'PRKAA1', 'DOCK3', 'IRS2', 'FOXO3', 'MAPK9', 'MAPK8', 'CDH2', 'CFL1', 'NCAM1', 'FYN', 'GRIA3', 'NSF', 'STAT5B', 'CDKL5', 'MAP3K1', 'KSR1', 'KIDINS220', 'SORT1', 'RPS6', 'RANBP9', 'GRIN2B', 'TIAM1', 'RPS6KB1', 'APC', 'RAF1']",0.9996167817520385,0,0,27
216,Classical pathway of steroidogenesis with glucocorticoid and mineralocorticoid metabolism WP4523,0.45986178230182834,1.4435066396578888,1.1213582638446333,"['HSD11B1', 'H6PD']",0.9996167817520385,0,0,2
217,Disorders of Folate Metabolism and Transport WP4259,0.45986178230182834,1.4435066396578888,1.1213582638446333,"['SLC46A1', 'ALDH1L1']",0.9996167817520385,0,0,2
218,Heme Biosynthesis WP561,0.45986178230182834,1.4435066396578888,1.1213582638446333,"['UROD', 'UROS']",0.9996167817520385,0,0,2
219,HIF1A and PPARG regulation of glycolysis WP2456,0.45986178230182834,1.4435066396578888,1.1213582638446333,"['LDHA', 'GAPDH']",0.9996167817520385,0,0,2
220,Interleukin-1 Induced Activation of NF-kappa-B WP3656,0.45986178230182834,1.4435066396578888,1.1213582638446333,"['TIFA', 'UBE2N']",0.9996167817520385,0,0,2
221,Irinotecan pathway WP229,0.45986178230182834,1.4435066396578888,1.1213582638446333,"['ABCC1', 'CYP3A5']",0.9996167817520385,0,0,2
222,Macrophage markers WP4146,0.45986178230182834,1.4435066396578888,1.1213582638446333,"['CD83', 'CD14']",0.9996167817520385,0,0,2
223,Methylation Pathways WP704,0.45986178230182834,1.4435066396578888,1.1213582638446333,"['MAT2B', 'COMT']",0.9996167817520385,0,0,2
224,Urea cycle and related diseases WP4571,0.45986178230182834,1.4435066396578888,1.1213582638446333,"['SLC25A15', 'CPS1']",0.9996167817520385,0,0,2
225,Regulation of toll-like receptor signaling pathway WP1449,0.47203007797059443,1.043576479832373,0.7834259821192272,"['CUEDC2', 'CISH', 'PELI3', 'TNFAIP3', 'PIK3CB', 'MAPK9', 'MAPK8', 'RNF216', 'TRAF3', 'TOLLIP', 'AKT3', 'TIFA', 'PELI1', 'SARM1', 'MAP3K8', 'PTPN6', 'CD14', 'MAP3K7', 'IKBKE', 'MAP2K6']",0.9996167817520385,0,0,20
226,Gastric Cancer Network 1 WP2361,0.4783412084342761,1.139609754362249,0.8403835333801655,"['CCNA1', 'NUP107', 'RNF216', 'APC', 'CEP192']",0.9996167817520385,0,0,5
227,Wnt/beta-catenin signaling pathway in leukemia WP3658,0.4783412084342761,1.139609754362249,0.8403835333801655,"['PYGO1', 'APC', 'FZD6', 'LRP6', 'RUNX1T1']",0.9996167817520385,0,0,5
228,NO/cGMP/PKG mediated Neuroprotection WP4008,0.4837778973063266,1.082628552097429,0.7861283857185107,"['GUCY1A2', 'GRIN2A', 'AKAP9', 'TSPO', 'NOS1', 'CALM1', 'GRIN2B', 'CALM2']",0.9996167817520385,0,0,8
229,Ebstein-Barr virus LMP1 signaling WP262,0.4898558984835892,1.1547747747747747,0.8240981076797405,"['MAPK8', 'MAP3K7', 'MAP3K14', 'PDLIM7']",0.9996167817520385,0,0,4
230,Oxysterols derived from cholesterol WP4545,0.4932556487108463,1.0826006087250593,0.7651038188670116,"['ACOT9', 'CH25H', 'EBP', 'AMACR', 'SCP2', 'ACOT11', 'ACOT4']",0.9996167817520385,0,0,7
231,Renin-angiotensin-aldosterone system (RAAS) WP4756,0.4932556487108463,1.0826006087250593,0.7651038188670116,"['ATF1', 'CREB3', 'CAMK1D', 'GNAQ', 'ITPR1', 'CALM1', 'CALM2']",0.9996167817520385,0,0,7
232,Apoptosis-related network due to altered Notch3 in ovarian cancer WP2864,0.4948458656618223,1.0561949898442788,0.7430426255591633,"['CDKN1B', 'HSPA5', 'RPS6KB1', 'HDAC1', 'ANXA5', 'CUL1', 'ABL1', 'PAK2', 'TNFRSF21', 'PTK2']",0.9996167817520385,0,0,10
233,Cardiac Hypertrophic Response WP2795,0.4948458656618223,1.0561949898442788,0.7430426255591633,"['MAPK8', 'MAP3K1', 'IGF1', 'RAF1', 'CALM1', 'MAP3K7', 'IKBKE', 'MAP3K14', 'CALM2', 'MAP2K6']",0.9996167817520385,0,0,10
234,Phosphodiesterases in neuronal function WP4222,0.4948458656618223,1.0561949898442788,0.7430426255591633,"['GRIA1', 'GUCY1A2', 'GRIN2A', 'ADORA2A', 'PDE1C', 'PDE6G', 'PDE1A', 'NOS1', 'GRIN2B', 'ADCY5']",0.9996167817520385,0,0,10
235,Endoplasmic reticulum stress response in coronavirus infection WP4861,0.5038620698281385,1.0533132116888462,0.7219964052703636,"['PPP1R3G', 'PPP1R3F', 'MAPK8', 'PPP1R13B', 'HSPA5', 'PPP1R1A', 'PPP1R9A', 'PPP1R12B', 'ATF6']",0.9996167817520385,0,0,9
236,Galanin receptor pathway WP4970,0.5045819952704089,1.180989223542415,0.8078260645917161,"['YAP1', 'CDKN1B', 'PPARGC1A']",0.9996167817520385,0,0,3
237,Leptin Insulin Overlap WP3935,0.5045819952704089,1.180989223542415,0.8078260645917161,"['SOCS2', 'INSR', 'IRS2']",0.9996167817520385,0,0,3
238,Epithelial to mesenchymal transition in colorectal cancer WP4239,0.5089827316326992,1.0142709080762178,0.684978921101878,"['NOTCH2', 'SPARC', 'TUSC3', 'NOTCH4', 'EIF5A2', 'PIK3CB', 'PKD1', 'LRP6', 'DLL4', 'MAPK8', 'CDH2', 'AKT3', 'MAP2K6', 'FZD1', 'SMAD2', 'TGFB2', 'SMAD4', 'EED', 'NUBPL', 'FZD6', 'FZD9', 'FMNL2', 'CLDN9', 'COL4A5', 'KRAS', 'RAF1']",0.9996167817520385,0,0,26
239,Male infertility WP4673,0.5163468128215737,1.0156909597769812,0.6713479789792692,"['SLC46A1', 'CREBBP', 'PACRG', 'CCNT2', 'INSR', 'PON2', 'HMGA1', 'CXXC1', 'CHD2', 'CDC42BPA', 'REC8', 'ARNTL', 'CCNA1', 'EP300', 'SLC16A7', 'ATM', 'NOS1', 'RAG1', 'BRDT']",0.9996167817520385,0,0,19
240,Ovarian infertility WP34,0.5170947347095594,1.0825447786414328,0.7139698723103095,"['CDKN1B', 'NCOR1', 'ATM', 'PRLR', 'SYNE2']",0.9996167817520385,0,0,5
241,"Degradation pathway of sphingolipids, including diseases WP4153",0.5256433516370478,1.2371949455001447,0.7956800740624482,"['GLB1', 'NEU1']",0.9996167817520385,0,0,2
242,Role of Osx and miRNAs in tooth development WP3971,0.5256433516370478,1.2371949455001447,0.7956800740624482,"['NOTCH2', 'NOTCH4']",0.9996167817520385,0,0,2
243,Serotonin Transporter Activity WP1455,0.5256433516370478,1.2371949455001447,0.7956800740624482,"['MAOA', 'NOS1']",0.9996167817520385,0,0,2
244,Somitogenesis in the context of spondylocostal dysostosis WP4785,0.5256433516370478,1.2371949455001447,0.7956800740624482,"['EPHA4', 'TBX6']",0.9996167817520385,0,0,2
245,Exercise-induced Circadian Regulation WP410,0.5318873624944501,1.0255142933475823,0.6474313106041975,"['DAZAP2', 'PER1', 'TUBB3', 'ZFR', 'GFRA1', 'QKI', 'EIF4G2', 'ARNTL', 'ETV6']",0.9996167817520385,0,0,9
246,TGF-beta receptor signaling in skeletal dysplasias WP4816,0.5318873624944501,1.0255142933475823,0.6474313106041975,"['SMAD2', 'MAPK9', 'CREBBP', 'SMAD4', 'ZFYVE9', 'EP300', 'LTBP3', 'SMAD5', 'ADAMTS10']",0.9996167817520385,0,0,9
247,Hippo-Yap signaling pathway WP4537,0.5330951486263126,1.082516891891892,0.6809630482658421,"['LATS1', 'STK38L', 'MAP4K3', 'MAP4K4']",0.9996167817520385,0,0,4
248,Metabolism of Spingolipids in ER and Golgi apparatus WP4142,0.5330951486263126,1.082516891891892,0.6809630482658421,"['UGT8', 'CERK', 'GALNT1', 'SGPP2']",0.9996167817520385,0,0,4
249,"Relationship between inflammation, COX-2 and EGFR WP4483",0.5330951486263126,1.082516891891892,0.6809630482658421,"['PTGES2', 'AKT3', 'KRAS', 'PIK3CB']",0.9996167817520385,0,0,4
250,Triacylglyceride synthesis WP325,0.5330951486263126,1.082516891891892,0.6809630482658421,"['LIPE', 'GPAM', 'AGPS', 'AGPAT4']",0.9996167817520385,0,0,4
251,Vitamin D in inflammatory diseases WP4482,0.5330951486263126,1.082516891891892,0.6809630482658421,"['SMAD4', 'MAP3K1', 'RXRA', 'MAP2K6']",0.9996167817520385,0,0,4
252,AGE/RAGE pathway WP2324,0.5373848794202228,1.0133654199479794,0.6293411897666596,"['SMAD2', 'MAPK9', 'STAT5B', 'MAPK8', 'ROCK1', 'SP1', 'INSR', 'MSN', 'INHBB', 'EZR', 'RAF1']",0.9996167817520385,0,0,11
253,Pancreatic adenocarcinoma pathway WP4263,0.5383311404765316,1.0039918982164278,0.6217535137577566,"['RB1', 'SMAD2', 'TGFB2', 'SMAD4', 'PIK3CB', 'TIAM1', 'MAPK9', 'MAPK8', 'RPS6KB1', 'AKT3', 'E2F1', 'RAC3', 'KRAS', 'RAF1', 'PAK2', 'PAK5']",0.9996167817520385,0,0,16
254,Pathways Regulating Hippo Signaling WP4540,0.5383311404765316,1.0039918982164278,0.6217535137577566,"['SMAD2', 'PRKAA1', 'PRKCE', 'INSR', 'GNAI3', 'PRKAG2', 'CDH7', 'CDH6', 'LATS1', 'CDH2', 'CDH20', 'PRKAR2A', 'GNAQ', 'CDH10', 'KIT', 'PRKACA']",0.9996167817520385,0,0,16
255,Cardiac Progenitor Differentiation WP2406,0.5386723642005036,1.0391886409736308,0.642891716143719,"['BMP1', 'TNNT2', 'KIT', 'NCAM1', 'THY1', 'IGF1']",0.9996167817520385,0,0,6
256,Eukaryotic Transcription Initiation WP405,0.5434793843459014,1.0187853219772347,0.6212181081871925,"['GTF2A2', 'GTF2B', 'POLR2C', 'ILK', 'TAF7', 'POLR3H', 'TAF6', 'POLR2J']",0.9996167817520385,0,0,8
257,Folate Metabolism WP176,0.5434793843459014,1.0187853219772347,0.6212181081871925,"['SLC46A1', 'GPX2', 'AHCY', 'GPX3', 'RFK', 'INSR', 'PLG', 'NOS1']",0.9996167817520385,0,0,8
258,Notch Signaling WP268,0.5434793843459014,1.0187853219772347,0.6212181081871925,"['NOTCH2', 'APH1A', 'DLL4', 'CREBBP', 'HDAC1', 'NOTCH4', 'DVL2', 'DTX2']",0.9996167817520385,0,0,8
259,IL-1 signaling pathway WP195,0.547788872612065,1.0069121884397978,0.6060255418378189,"['MAPK9', 'MAPK8', 'MAP3K1', 'TOLLIP', 'MAPKAPK2', 'PELI1', 'UBE2N', 'MAP3K7', 'MAP3K14', 'MAP2K6']",0.9996167817520385,0,0,10
260,Wnt signaling pathway and pluripotency WP399,0.5505769734741189,0.9946120195526371,0.5935730231241878,"['FZD1', 'CREBBP', 'PRKCE', 'LRRK2', 'FZD6', 'FZD9', 'PPP2R2A', 'PPM1J', 'PPP2R5C', 'LRP6', 'MAPK9', 'PPP2R1B', 'APC', 'PPP2R2B', 'DVL2', 'EP300', 'MAP3K7']",0.9996167817520385,0,0,17
261,Biomarkers for pyrimidine metabolism disorders WP4584,0.5542650247996576,1.0824890239783858,0.6387901120305468,"['RRM2B', 'DPYS', 'DPYD']",0.9996167817520385,0,0,3
262,Extracellular vesicles in the crosstalk of cardiac cells WP4300,0.5542650247996576,1.0824890239783858,0.6387901120305468,"['PTEN', 'SORBS2', 'IGF1']",0.9996167817520385,0,0,3
263,Overview of nanoparticle effects WP3287,0.5542650247996576,1.0824890239783858,0.6387901120305468,"['LAMA3', 'AKT3', 'PTK2']",0.9996167817520385,0,0,3
264,16p11.2 distal deletion syndrome WP4950,0.5545744234633505,1.0309145625130756,0.6077800760990153,"['RAB4A', 'RABEP2', 'INSR', 'TUFM', 'SDCCAG8']",0.9996167817520385,0,0,5
265,IL-5 signaling pathway WP127,0.5566980800207043,1.0102694172021192,0.5917473613225874,"['STAT5B', 'GSK3A', 'RPS6KB1', 'RPS6', 'KRAS', 'FOXO3', 'RAF1']",0.9996167817520385,0,0,7
266,TNF related weak inducer of apoptosis (TWEAK) Signaling Pathway WP2036,0.5566980800207043,1.0102694172021192,0.5917473613225874,"['MAPK9', 'MAPK8', 'HDAC1', 'TRAF3', 'RAF1', 'MAP3K7', 'MAP3K14']",0.9996167817520385,0,0,7
267,ErbB signaling pathway WP673,0.5588276842608693,0.9895716224074433,0.5758456904136596,"['STAT5B', 'CDKN1B', 'CBLB', 'PIK3CB', 'NRG2', 'CBL', 'PTK2', 'MAPK9', 'MAPK8', 'RPS6KB1', 'AKT3', 'ABL1', 'KRAS', 'RAF1', 'PAK2', 'PAK5']",0.9996167817520385,0,0,16
268,Nonalcoholic fatty liver disease WP4396,0.5641719627932203,0.9838689721302855,0.5631628367289812,"['CEBPA', 'NDUFB9', 'GSK3A', 'PRKAA1', 'NDUFB11', 'PRKAG2', 'IRS2', 'PIK3CB', 'COX6A1', 'ADIPOR1', 'COX5B', 'COX5A', 'MAPK9', 'MAPK8', 'RXRA', 'AKT3', 'MLX', 'CYC1', 'COX8A', 'INSR', 'MLXIPL', 'ITCH', 'NDUFS4', 'NDUFS3', 'PPARA']",0.9996167817520385,0,0,25
269,Activation of NLRP3 Inflammasome by SARS-CoV-2 WP4876,0.5645113984675016,1.4433569580380246,0.8253038637914758,['TRAF3'],0.9996167817520385,0,0,1
270,Aflatoxin B1 metabolism WP699,0.5645113984675016,1.4433569580380246,0.8253038637914758,['EPHX1'],0.9996167817520385,0,0,1
271,Effects of nitric oxide WP1995,0.5645113984675016,1.4433569580380246,0.8253038637914758,['NOS1'],0.9996167817520385,0,0,1
272,Gastric acid production WP2596,0.5645113984675016,1.4433569580380246,0.8253038637914758,['CCK'],0.9996167817520385,0,0,1
273,Nanomaterial-induced inflammasome activation WP3890,0.5645113984675016,1.4433569580380246,0.8253038637914758,['CTSB'],0.9996167817520385,0,0,1
274,SARS-CoV-2 altering angiogenesis via NRP1 WP5065,0.5645113984675016,1.4433569580380246,0.8253038637914758,['NRP1'],0.9996167817520385,0,0,1
275,Secretion of Hydrochloric Acid in Parietal Cells WP2597,0.5645113984675016,1.4433569580380246,0.8253038637914758,['CHRM1'],0.9996167817520385,0,0,1
276,Head and Neck Squamous Cell Carcinoma WP4674,0.5648701008562982,0.9874024267717753,0.563964260829968,"['RB1', 'NOTCH2', 'PRKAA1', 'SMAD4', 'RPS6', 'PTEN', 'PIK3CB', 'RPTOR', 'TRAF3', 'AKT3', 'E2F1', 'KRAS', 'CSMD3']",0.9996167817520385,0,0,13
277,Glioblastoma signaling pathways WP2261,0.5676085294240945,0.9839236721230618,0.5572189074731089,"['RB1', 'CDKN1B', 'PTEN', 'PIK3CB', 'FOXO3', 'CBL', 'AKT3', 'E2F1', 'NF1', 'EP300', 'ATM', 'KRAS', 'MDM4', 'RAF1', 'MAP2K6']",0.9996167817520385,0,0,15
278,Peptide GPCRs WP24,0.5722802481408157,0.9895998453508602,0.5523218617518065,"['MC4R', 'OPRD1', 'ATP8A1', 'OPRL1', 'TAC4', 'SSTR1', 'OPRM1', 'SSTR3']",0.9996167817520385,0,0,8
279,Differentiation of white and brown adipocyte WP2895,0.5744209379724353,1.0187599364069952,0.5647931838708994,"['CEBPA', 'PRDM16', 'PPARGC1A', 'SMAD5']",0.9996167817520385,0,0,4
280,Purinergic signaling WP4900,0.5744209379724353,1.0187599364069952,0.5647931838708994,"['P2RX7', 'P2RY11', 'ADORA2A', 'GNAI3']",0.9996167817520385,0,0,4
281,MicroRNAs in cardiomyocyte hypertrophy WP1544,0.5769945968706742,0.977550574084199,0.5375769350384678,"['FZD1', 'MYEF2', 'CISH', 'ROCK1', 'PIK3CB', 'IGF1', 'LRP6', 'MAPK8', 'RAF1', 'CALM1', 'IKBKE', 'CALM2', 'MAP3K14', 'MAP2K6']",0.9996167817520385,0,0,14
282,Bone morphogenic protein (BMP) signaling and regulation WP1425,0.5857636083044929,1.0824611748818367,0.5789424193950922,"['SMAD4', 'BMPR1A']",0.9996167817520385,0,0,2
283,EDA signaling in hair follicle development WP3930,0.5857636083044929,1.0824611748818367,0.5789424193950922,"['BMP1', 'SOSTDC1']",0.9996167817520385,0,0,2
284,Ethanol metabolism resulting in production of ROS by CYP2E1 WP4269,0.5857636083044929,1.0824611748818367,0.5789424193950922,"['MAPK8', 'SP1']",0.9996167817520385,0,0,2
285,Gene regulatory network modelling somitogenesis  WP2854,0.5857636083044929,1.0824611748818367,0.5789424193950922,"['EPHA4', 'TBX6']",0.9996167817520385,0,0,2
286,Nanoparticle triggered regulated necrosis WP2513,0.5857636083044929,1.0824611748818367,0.5789424193950922,"['MAPK8', 'FTL']",0.9996167817520385,0,0,2
287,Neuroinflammation WP4919,0.5857636083044929,1.0824611748818367,0.5789424193950922,"['MAPK8', 'ASCC1']",0.9996167817520385,0,0,2
288,TCA cycle in senescence WP5050,0.5857636083044929,1.0824611748818367,0.5789424193950922,"['MDH1', 'ME1']",0.9996167817520385,0,0,2
289,Monoamine GPCRs WP58,0.5905579985566739,0.983978002396387,0.5182488440447339,"['CHRM3', 'CHRM1', 'ADRA1A', 'DRD3', 'ADRA2A']",0.9996167817520385,0,0,5
290,mRNA Processing WP411,0.5945226381397004,0.9665492550912278,0.5026022145340601,"['SRPK2', 'RBM39', 'RNGTT', 'DHX9', 'CELF1', 'NCBP2', 'SFSWAP', 'DDX1', 'CELF2', 'CELF4', 'PRPF40A', 'DICER1', 'SMC1A', 'HNRNPK', 'DHX15', 'SPOP', 'CD2BP2', 'SRSF3', 'DHX38', 'SRSF4', 'CLASRP', 'RBM5', 'SRSF9']",0.9996167817520385,0,0,23
291,Endochondral Ossification with Skeletal Dysplasias WP4808,0.5984901546538546,0.9620100804934928,0.49384326116985305,"['STAT5B', 'TGFB2', 'HMGCS1', 'CHST11', 'SOX9', 'IGF1', 'PRKACA', 'CALM1', 'CALM2', 'BMPR1A']",0.9996167817520385,0,0,10
292,Endochondral Ossification WP474,0.5984901546538546,0.9620100804934928,0.49384326116985305,"['STAT5B', 'TGFB2', 'HMGCS1', 'CHST11', 'SOX9', 'IGF1', 'PRKACA', 'CALM1', 'CALM2', 'BMPR1A']",0.9996167817520385,0,0,10
293,MAPK pathway in congenital thyroid cancer WP4928,0.6008360498286462,0.9991427012703609,0.5089964408729116,"['KSR1', 'KRAS', 'RAF1']",0.9996167817520385,0,0,3
294,SARS coronavirus and innate immunity WP4912,0.6008360498286462,0.9991427012703609,0.5089964408729116,"['DDX58', 'TRAF3', 'IKBKE']",0.9996167817520385,0,0,3
295,Amyotrophic lateral sclerosis (ALS) WP2447,0.6042797875111626,0.9620614529336639,0.48460763626303527,"['GRIA1', 'PPP3CC', 'APAF1', 'NEFM', 'NOS1', 'MAP2K6']",0.9996167817520385,0,0,6
296,MAPK Cascade WP422,0.6042797875111626,0.9620614529336639,0.48460763626303527,"['MAP3K1', 'MAP2', 'KRAS', 'RAF1', 'MAP2K6', 'MAP3K12']",0.9996167817520385,0,0,6
297,Nuclear receptors WP170,0.6042797875111626,0.9620614529336639,0.48460763626303527,"['THRB', 'RXRA', 'HNF4A', 'RARB', 'PPARA', 'NR2F6']",0.9996167817520385,0,0,6
298,Target Of Rapamycin (TOR) Signaling WP1471,0.6042797875111626,0.9620614529336639,0.48460763626303527,"['RPTOR', 'PRKAA1', 'RRAGA', 'RPS6KB1', 'ULK3', 'PRKAG2']",0.9996167817520385,0,0,6
299,G1 to S cell cycle control WP45,0.6098175636668518,0.9523399932272265,0.4710230203634228,"['RB1', 'ORC5', 'CCNA1', 'CREB3', 'CDKN1B', 'CCNE2', 'ORC2', 'MCM3', 'E2F1', 'ATM', 'MYT1']",0.9996167817520385,0,0,11
300,Interferon type I signaling pathways WP585,0.6120398392492313,0.950253807106599,0.4665346152917564,"['RPTOR', 'MAP3K1', 'RPS6KB1', 'RPS6', 'IRS2', 'FYN', 'PTPN6', 'CBL', 'MAP2K6']",0.9996167817520385,0,0,9
301,RANKL/RANK signaling pathway WP2018,0.6120398392492313,0.950253807106599,0.4665346152917564,"['MAPK9', 'MAPK8', 'TRAF3', 'CTSK', 'MITF', 'CBL', 'MAP3K7', 'PTK2', 'MAP2K6']",0.9996167817520385,0,0,9
302,NRF2-ARE regulation WP4357,0.6135882266925365,0.9620870870870871,0.4699133662102769,"['MAPK8', 'YES1', 'INSR', 'FYN']",0.9996167817520385,0,0,4
303,DNA IR-damage and cellular response via ATR WP4016,0.6188482033319788,0.9468538135593221,0.4543906619987187,"['BARD1', 'SMARCAL1', 'MRE11', 'POLN', 'XPA', 'SMC1A', 'RAD52', 'BRIP1', 'HERC2', 'SP1', 'E2F1', 'USP1', 'ATM', 'RAD9A']",0.9996167817520385,0,0,14
304,Endothelin Pathways WP2197,0.6248735939702287,0.9411228822898453,0.4425215312646318,"['ATP2A2', 'RAF1', 'CALM1', 'ADRA1A', 'CALM2']",0.9996167817520385,0,0,5
305,PDGFR-beta pathway WP3972,0.6248735939702287,0.9411228822898453,0.4425215312646318,"['STAT5B', 'MAPK8', 'MAP3K1', 'RASA1', 'RAF1']",0.9996167817520385,0,0,5
306,p38 MAPK Signaling Pathway WP400,0.6350916363358498,0.9276296725586787,0.4211308671894754,"['TGFB2', 'MAP3K1', 'MKNK1', 'MAPKAPK2', 'MAP3K7', 'MAP2K6']",0.9996167817520385,0,0,6
307,Signaling of Hepatocyte Growth Factor Receptor WP313,0.6350916363358498,0.9276296725586787,0.4211308671894754,"['ITGB1', 'MAPK8', 'RASA1', 'PTEN', 'RAF1', 'PTK2']",0.9996167817520385,0,0,6
308,Amino Acid metabolism WP3925,0.6390138486610984,0.9322138200782268,0.41747252494161924,"['MPST', 'MDH1', 'MAOA', 'MCCC1', 'GOT2', 'GLS', 'ACLY', 'LDHA', 'PKM', 'AUH', 'CPS1', 'ALDH1A1', 'OGDH', 'ALDH18A1']",0.9996167817520385,0,0,14
309,Alanine and aspartate metabolism WP106,0.640030634320121,0.9621126866231525,0.4293324318109322,"['GOT2', 'GAD2']",0.9996167817520385,0,0,2
310,Sulfation Biotransformation Reaction WP692,0.640030634320121,0.9621126866231525,0.4293324318109322,"['G6PD', 'PAPSS1']",0.9996167817520385,0,0,2
311,Transcriptional cascade regulating adipogenesis WP4211,0.640030634320121,0.9621126866231525,0.4293324318109322,"['CEBPA', 'KLF15']",0.9996167817520385,0,0,2
312,Nuclear Receptors Meta-Pathway WP2882,0.6415255880749712,0.9518013698630137,0.4225105367147326,"['CDKN1B', 'SRXN1', 'ABHD2', 'CUL1', 'TNFAIP3', 'IRS2', 'SLC5A2', 'CYP3A5', 'AKAP13', 'FGD4', 'RXRA', 'SCP2', 'ZIC2', 'PRDX1', 'DNER', 'ENC1', 'SLC39A6', 'ME1', 'EP300', 'STOM', 'PPARGC1A', 'SLC39A1', 'GSTM4', 'SRGN', 'CBR1', 'G6PD', 'TGFB2', 'GPX2', 'NCOA6', 'GPX3', 'PLK2', 'AIP', 'ARNT', 'SLC39A12', 'SMC1A', 'GPAM', 'NAV3', 'SP1', 'ADGRF4', 'BHLHE40', 'SPRY1', 'PPARA', 'GSTM5', 'FTL']",0.9996167817520385,0,0,44
313,Matrix Metalloproteinases WP129,0.6440736117689158,0.9277029960920539,0.40813574846154527,"['MMP16', 'MMP26', 'TCF20']",0.9996167817520385,0,0,3
314,MFAP5 effect on permeability and motility of endothelial cells via cytoskeleton rearrangement WP4560,0.6440736117689158,0.9277029960920539,0.40813574846154527,"['ACTN1', 'ITPR1', 'PTK2']",0.9996167817520385,0,0,3
315,PPAR-alpha pathway WP2878,0.6440736117689158,0.9277029960920539,0.40813574846154527,"['RXRA', 'SCP2', 'PPARA']",0.9996167817520385,0,0,3
316,Copper homeostasis WP3286,0.644479472544141,0.9182115370820139,0.40338162895706553,"['ATP7B', 'APC', 'SCO2', 'SP1', 'COX17', 'PTEN', 'FOXO3']",0.9996167817520385,0,0,7
317,Nephrotic syndrome WP4758,0.644479472544141,0.9182115370820139,0.40338162895706553,"['SMARCAL1', 'PTPRO', 'PDSS2', 'MYH9', 'COL4A5', 'GPC5', 'PAX2']",0.9996167817520385,0,0,7
318,Benzene metabolism WP3891,0.6462428630921284,1.0824333445831926,0.47256863786197445,['EPHX1'],0.9996167817520385,0,0,1
319,Mitochondrial fatty acid synthesis pathway WP4317,0.6462428630921284,1.0824333445831926,0.47256863786197445,['ACACA'],0.9996167817520385,0,0,1
320,Robo4 and VEGF Signaling Pathways Crosstalk WP3943,0.6462428630921284,1.0824333445831926,0.47256863786197445,['SLIT2'],0.9996167817520385,0,0,1
321,The alternative pathway of fetal androgen synthesis WP4524,0.6462428630921284,1.0824333445831926,0.47256863786197445,['HSD17B6'],0.9996167817520385,0,0,1
322,MET in type 1 papillary renal cell carcinoma WP4205,0.6463275405820893,0.9209294285426181,0.4019386129776695,"['MAPK8', 'AKT3', 'KRAS', 'STRN', 'PIK3CB', 'RAF1', 'CBL', 'PAK2', 'PAK5', 'PTK2']",0.9996167817520385,0,0,10
323,Notch Signaling Pathway Netpath WP61,0.6463275405820893,0.9209294285426181,0.4019386129776695,"['NOTCH2', 'DLL4', 'APH1A', 'SPEN', 'ITCH', 'NCOR1', 'HDAC1', 'NOTCH4', 'CUL1', 'EP300']",0.9996167817520385,0,0,10
324,Hypothesized Pathways in Pathogenesis of Cardiovascular Disease WP3668,0.650430106740986,0.911379800853485,0.3920039852601712,"['SMAD2', 'MAPK8', 'POSTN', 'SMAD4']",0.9996167817520385,0,0,4
325,miRNA regulation of p53 pathway in prostate cancer WP3982,0.650430106740986,0.911379800853485,0.3920039852601712,"['APAF1', 'SHISA5', 'PTEN', 'ATM']",0.9996167817520385,0,0,4
326,Trans-sulfuration and one-carbon metabolism WP2525,0.650430106740986,0.911379800853485,0.3920039852601712,"['AHCYL2', 'DNMT1', 'AHCY', 'MAT2B']",0.9996167817520385,0,0,4
327,RAC1/PAK1/p38/MMP2 Pathway WP3303,0.654877929054972,0.9155682617416447,0.3875659309903897,"['ITGB1', 'YAP1', 'GRB7', 'MAPK9', 'STAT5B', 'MAPK8', 'TNIP1', 'RASA1', 'KRAS', 'NOS1', 'PTK2']",0.9996167817520385,0,0,11
328,Myometrial relaxation and contraction pathways WP289,0.6651278582268955,0.9271865889212828,0.3780844280967297,"['ATF1', 'YWHAE', 'RGS14', 'GSTO1', 'PRKCE', 'ITPR1', 'ATP2A2', 'ARRB2', 'RXFP2', 'RYR3', 'ADCY5', 'CREB3', 'RGS1', 'SP1', 'PRKAR2A', 'GNAQ', 'IGFBP6', 'NOS1', 'PRKACA', 'ATF5', 'CALM1', 'CALM2', 'RGS6', 'YWHAG']",0.9996167817520385,0,0,24
329,T-cell receptor (TCR) signaling pathway WP69,0.6704679844447918,0.9074179337785988,0.3627669301276194,"['CD83', 'FYB1', 'ITPR1', 'CBLB', 'OPRM1', 'CBL', 'MAPK9', 'MAPK8', 'MAP3K8', 'FYN', 'RAF1', 'MAP3K7', 'MAP3K14']",0.9996167817520385,0,0,13
330,Thyroid hormones production and their peripheral downstream signaling effects WP4746,0.6776388638705966,0.9042448773083734,0.35187855877303265,"['THRB', 'RPS6', 'RPTOR', 'MC4R', 'CREB3', 'RPS6KA6', 'RXRA', 'RPS6KB1', 'AKT3', 'PRDM16', 'PRKACA', 'RAF1', 'MAP4K5', 'PPARGC1A']",0.9996167817520385,0,0,14
331,Chromosomal and microsatellite instability in colorectal cancer  WP4216,0.6831823126292109,0.8953602467059153,0.3411264572999072,"['SMAD2', 'MAPK9', 'MAPK8', 'TGFB2', 'SMAD4', 'APC', 'DCC', 'AKT3', 'RAC3', 'KRAS', 'RAF1', 'EXOC2']",0.9996167817520385,0,0,12
332,Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells WP4301,0.6838812072178352,0.8657885849375211,0.3289745977839423,"['RRAS2', 'KRAS', 'RAF1']",0.9996167817520385,0,0,3
333,Nanomaterial induced apoptosis WP2507,0.6838812072178352,0.8657885849375211,0.3289745977839423,"['ENDOG', 'APAF1', 'HTRA2']",0.9996167817520385,0,0,3
334,TCA Cycle (aka Krebs or citric acid cycle) WP78,0.6838812072178352,0.8657885849375211,0.3289745977839423,"['SUCLA2', 'OGDH', 'IDH3A']",0.9996167817520385,0,0,3
335,Canonical and non-canonical Notch signaling WP3845,0.6848478547653161,0.8657432432432433,0.3277345286698969,"['NOTCH2', 'DLL4', 'NOTCH4', 'DNER']",0.9996167817520385,0,0,4
336,"Oligodendrocyte specification and differentiation, leading to myelin components for CNS WP4304",0.6848478547653161,0.8657432432432433,0.3277345286698969,"['OMG', 'SOX9', 'IGF1', 'MYT1']",0.9996167817520385,0,0,4
337,Signal Transduction of S1P Receptor WP26,0.6848478547653161,0.8657432432432433,0.3277345286698969,"['AKT3', 'GNAI3', 'S1PR1', 'MAPK6']",0.9996167817520385,0,0,4
338,Genes controlling nephrogenesis WP4823,0.6880424687148761,0.8656978709023319,0.32368851584355246,"['NOTCH2', 'ITGB1', 'ILK', 'SLIT2', 'PAX2']",0.9996167817520385,0,0,5
339,Overview of leukocyte-intrinsic Hippo pathway functions WP4542,0.6880424687148761,0.8656978709023319,0.32368851584355246,"['YAP1', 'LATS1', 'FYB1', 'STK38L', 'FOXO3']",0.9996167817520385,0,0,5
340,Genes targeted by miRNAs in adipocytes WP1992,0.6885237448818916,0.8658338960162053,0.32313394918896277,"['IGF1', 'ERG']",0.9996167817520385,0,0,2
341,Iron metabolism in placenta WP2007,0.6885237448818916,0.8658338960162053,0.32313394918896277,"['TF', 'ACO1']",0.9996167817520385,0,0,2
342,MFAP5-mediated ovarian cancer cell motility and invasiveness WP3301,0.6885237448818916,0.8658338960162053,0.32313394918896277,"['RYR3', 'PTK2']",0.9996167817520385,0,0,2
343,NO metabolism in cystic fibrosis WP4947,0.6885237448818916,0.8658338960162053,0.32313394918896277,"['DDAH1', 'NOS1']",0.9996167817520385,0,0,2
344,Osteoclast Signaling WP12,0.6885237448818916,0.8658338960162053,0.32313394918896277,"['MAPK8', 'CTSK']",0.9996167817520385,0,0,2
345,Apoptosis Modulation and Signaling WP1772,0.6897561294008987,0.8929445493322146,0.33165494597608863,"['ENDOG', 'APAF1', 'HTRA2', 'PTPN13', 'PIDD1', 'MAPK8', 'TRAF3', 'PTRH2', 'TOLLIP', 'MADD', 'BIRC6', 'TNFRSF25', 'MAP3K14']",0.9996167817520385,0,0,13
346,Neural Crest Differentiation WP2064,0.6960399766651337,0.8908773678963111,0.3228077951410113,"['NOTCH2', 'ITGB1', 'HDAC1', 'NOTCH4', 'MITF', 'TBX6', 'CDH7', 'RHOB', 'CDH6', 'DLL4', 'GJB1', 'CDH2', 'DVL2', 'SOX9']",0.9996167817520385,0,0,14
347,Acute viral myocarditis WP4298,0.6968945219120821,0.8815203622179579,0.3183357009191518,"['ENDOG', 'RASA1', 'JKAMP', 'ABL1', 'ILK', 'RAC3', 'DMD', 'FYN', 'NOS1', 'EIF4G2', 'EIF4G1']",0.9996167817520385,0,0,11
348,Hepatitis B infection WP4666,0.7108761251492767,0.8978425663455741,0.30639514199870505,"['SMAD2', 'STAT5B', 'TGFB2', 'SMAD4', 'CREBBP', 'MAP3K1', 'ATP6AP1', 'APAF1', 'DDX58', 'NFATC3', 'PIK3CB', 'CREB3', 'MAPK9', 'MAPK8', 'TRAF3', 'AKT3', 'EP300', 'KRAS', 'RAF1', 'MAP3K7', 'IKBKE', 'MAP2K6']",0.9996167817520385,0,0,22
349,Cellular Proteostasis WP4918,0.712639311290214,0.8658791765102937,0.29334242735009836,['PFDN5'],0.9996167817520385,0,0,1
350,Eicosanoid metabolism via cytochrome P450 monooxygenases (CYP) pathway WP4720,0.712639311290214,0.8658791765102937,0.29334242735009836,['PPARA'],0.9996167817520385,0,0,1
351,Fatty Acid Omega Oxidation WP206,0.712639311290214,0.8658791765102937,0.29334242735009836,['ALDH1A1'],0.9996167817520385,0,0,1
352,Fluoroacetic acid toxicity WP4966,0.712639311290214,0.8658791765102937,0.29334242735009836,['ACSS2'],0.9996167817520385,0,0,1
353,FOXP3 in COVID-19 WP5063,0.712639311290214,0.8658791765102937,0.29334242735009836,['STAT5B'],0.9996167817520385,0,0,1
354,mir-124 predicted interactions with cell cycle and differentiation  WP3595,0.712639311290214,0.8658791765102937,0.29334242735009836,['PRKAA1'],0.9996167817520385,0,0,1
355,"Phase I biotransformations, non P450 WP136",0.712639311290214,0.8658791765102937,0.29334242735009836,['PON2'],0.9996167817520385,0,0,1
356,SARS-CoV-2 and COVID-19 Pathway WP4846,0.712639311290214,0.8658791765102937,0.29334242735009836,['NRP1'],0.9996167817520385,0,0,1
357,Somatic sex determination WP4814,0.712639311290214,0.8658791765102937,0.29334242735009836,['SOX9'],0.9996167817520385,0,0,1
358,Wnt signaling WP428,0.713409575602689,0.886137014975409,0.29924810102271354,"['FZD1', 'INVS', 'SERPINF1', 'CHD8', 'FZD6', 'FZD9', 'NFATC3', 'CXXC4', 'LRP6', 'MAPK9', 'PORCN', 'MAPK8', 'PPP3R2', 'PPP3CC', 'APC', 'DVL2', 'MAP3K7']",0.9996167817520385,0,0,17
359,Host-pathogen interaction of human coronaviruses - interferon induction WP4880,0.716767460092111,0.8323368081732394,0.2771713320111008,"['MAPK8', 'DDX58', 'TRAF3', 'IKBKE', 'MAP3K7']",0.9996167817520385,0,0,5
360,miRNA regulation of prostate cancer signaling pathways WP3981,0.716767460092111,0.8323368081732394,0.2771713320111008,"['CREBBP', 'CDKN1B', 'AKT3', 'KRAS', 'RAF1']",0.9996167817520385,0,0,5
361,Cannabinoid receptor signaling WP3869,0.7168007969537229,0.8244530244530245,0.27450765753356277,"['MAPK9', 'MAPK8', 'ADORA2A', 'PRKACA']",0.9996167817520385,0,0,4
362,Cell migration and invasion through p75NTR WP4561,0.7168007969537229,0.8244530244530245,0.27450765753356277,"['TIAM1', 'TRIO', 'KIDINS220', 'AKT3']",0.9996167817520385,0,0,4
363,Ethanol effects on histone modifications WP3996,0.7168007969537229,0.8244530244530245,0.27450765753356277,"['AHCY', 'ACSS2', 'HDAC1', 'ALDH1A1']",0.9996167817520385,0,0,4
364,Glycosylation and related congenital defects WP4521,0.7168007969537229,0.8244530244530245,0.27450765753356277,"['DPAGT1', 'TUSC3', 'ALG3', 'DOLK']",0.9996167817520385,0,0,4
365,Photodynamic therapy-induced unfolded protein response WP3613,0.7168007969537229,0.8244530244530245,0.27450765753356277,"['HSPA5', 'UBE2E1', 'DNAJB9', 'ATF6']",0.9996167817520385,0,0,4
366,STING pathway in Kawasaki-like disease and COVID-19 WP4961,0.7202609130930259,0.811613475177305,0.2663242687625641,"['ITPR1', 'NFKBIE', 'IKBKE']",0.9996167817520385,0,0,3
367,TGF-beta Receptor Signaling WP560,0.7211691803404016,0.8414966369819261,0.27506970181281615,"['SMAD2', 'MAPK9', 'CREBBP', 'SMAD4', 'ZFYVE9', 'EP300', 'SMAD5']",0.9996167817520385,0,0,7
368,Amplification and Expansion of Oncogenic Pathways as Metastatic Traits WP3678,0.7314985154868914,0.7870603400650666,0.24608235513379165,"['POSTN', 'EPAS1']",0.9996167817520385,0,0,2
369,Development and heterogeneity of the ILC family WP3893,0.7314985154868914,0.7870603400650666,0.24608235513379165,"['BCL11B', 'TOX']",0.9996167817520385,0,0,2
370,Ganglio Sphingolipid Metabolism WP1423,0.7314985154868914,0.7870603400650666,0.24608235513379165,"['B3GALT4', 'FUT1']",0.9996167817520385,0,0,2
371,H19 action Rb-E2F1 signaling and CDK-Beta-catenin activity WP3969,0.7314985154868914,0.7870603400650666,0.24608235513379165,"['RB1', 'E2F1']",0.9996167817520385,0,0,2
372,Hedgehog Signaling Pathway Netpath WP47,0.7314985154868914,0.7870603400650666,0.24608235513379165,"['SUFU', 'ARNTL']",0.9996167817520385,0,0,2
373,Major receptors targeted by epinephrine and norepinephrine WP4589,0.7314985154868914,0.7870603400650666,0.24608235513379165,"['ADRA2A', 'ADCY5']",0.9996167817520385,0,0,2
374,Nephrogenesis WP5052,0.7314985154868914,0.7870603400650666,0.24608235513379165,"['NOTCH2', 'PAX2']",0.9996167817520385,0,0,2
375,Simplified Depiction of MYD88 Distinct Input-Output Pathway WP3877,0.7314985154868914,0.7870603400650666,0.24608235513379165,"['TIFA', 'UBE2N']",0.9996167817520385,0,0,2
376,Hematopoietic Stem Cell Differentiation WP2849,0.7431249553980749,0.8114224137931034,0.24090406991599947,"['KCNH2', 'THRB', 'TRAF3IP3', 'ITGA2B', 'MXI1', 'RUNX1']",0.9996167817520385,0,0,6
377,Mitochondrial complex I assembly model OXPHOS system WP4324,0.7458200248305995,0.8242154778014047,0.24171846562749316,"['NDUFB9', 'NDUFB11', 'NUBPL', 'NDUFS4', 'NDUFS3', 'NDUFAF2', 'NDUFAF3', 'TMEM70']",0.9996167817520385,0,0,8
378,SARS-CoV-2 mitochondrial interactions WP5038,0.7462964670858667,0.7869164619164619,0.23027721253018751,"['NDUFB9', 'DDX58', 'TRAF3', 'IKBKE']",0.9996167817520385,0,0,4
379,Purine metabolism and related disorders WP4224,0.7532901246438872,0.7638119077418202,0.21639160549803324,"['PRPS1', 'RRM2B', 'PAICS']",0.9996167817520385,0,0,3
380,Selenium Micronutrient Network WP15,0.7537035514243482,0.8349284997118601,0.2360811732445824,"['PRDX3', 'GPX2', 'PRDX5', 'SELENOS', 'GPX3', 'RFK', 'PRDX1', 'INSR', 'PNPO', 'PLG', 'SELENOT']",0.9996167817520385,0,0,11
381,Osteoblast differentiation WP4787,0.7588069181119952,0.8550240291664365,0.23599340707938582,"['NOTCH2', 'FZD1', 'SMAD4', 'PRKCE', 'NOTCH4', 'FZD6', 'PIK3R4', 'FZD9', 'PIK3CB', 'SMAD5', 'LRP6', 'DLL4', 'MAPK9', 'MAPK8', 'SOX9', 'MAPK6', 'BMPR1A']",0.9996167817520385,0,0,17
382,Pathogenic Escherichia coli infection WP2272,0.766037157456597,0.8049847373886774,0.2145482367397883,"['ITGB1', 'ROCK1', 'TUBB3', 'ABL1', 'FYN', 'CD14', 'EZR', 'TUBA4A']",0.9996167817520385,0,0,8
383,PDGF Pathway WP2526,0.766173699503375,0.7867723892064663,0.20955397239459814,"['TIAM1', 'MAPK8', 'MAP3K1', 'RASA1', 'ARFIP2', 'RAF1']",0.9996167817520385,0,0,6
384,Disorders of the Krebs cycle WP4236,0.7665772108581652,0.7215097311283609,0.19179161140988807,['SUCLA2'],0.9996167817520385,0,0,1
385,Dual hijack model of Vif in HIV infection WP3300,0.7665772108581652,0.7215097311283609,0.19179161140988807,['RUNX1'],0.9996167817520385,0,0,1
386,Glial Cell Differentiation WP2276,0.7665772108581652,0.7215097311283609,0.19179161140988807,['MSN'],0.9996167817520385,0,0,1
387,Mevalonate pathway WP3963,0.7665772108581652,0.7215097311283609,0.19179161140988807,['HMGCS1'],0.9996167817520385,0,0,1
388,Nucleotide GPCRs WP80,0.7665772108581652,0.7215097311283609,0.19179161140988807,['ADORA2A'],0.9996167817520385,0,0,1
389,Tgif disruption of Shh signaling WP3674,0.7665772108581652,0.7215097311283609,0.19179161140988807,['SMAD2'],0.9996167817520385,0,0,1
390,Kennedy pathway from sphingolipids WP3933,0.7693178831914769,0.7214157101057844,0.1891920077892063,"['CHPT1', 'CEPT1']",0.9996167817520385,0,0,2
391,miR-509-3p alteration of YAP1/ECM axis WP3967,0.7693178831914769,0.7214157101057844,0.1891920077892063,"['YAP1', 'SPARC']",0.9996167817520385,0,0,2
392,Pathways of nucleic acid metabolism and innate immune sensing WP4705,0.7693178831914769,0.7214157101057844,0.1891920077892063,"['RNASEL', 'DDX58']",0.9996167817520385,0,0,2
393,Riboflavin and CoQ disorders WP5037,0.7693178831914769,0.7214157101057844,0.1891920077892063,"['RFK', 'PDSS2']",0.9996167817520385,0,0,2
394,IL17 signaling pathway WP2112,0.7733813829485585,0.7526439482961222,0.19341667853811817,"['TRAF3', 'SP1', 'MAP3K7', 'MAP3K14']",0.9996167817520385,0,0,4
395,Angiogenesis WP1539,0.7831016137394163,0.7213216255769447,0.17635795585457453,"['CREBBP', 'ARNT', 'PTK2']",0.9996167817520385,0,0,3
396,Glycerolipids and Glycerophospholipids WP4722,0.7831016137394163,0.7213216255769447,0.17635795585457453,"['GPAM', 'CHPT1', 'AGPAT4']",0.9996167817520385,0,0,3
397,IL-7 signaling pathway WP205,0.7831016137394163,0.7213216255769447,0.17635795585457453,"['STAT5B', 'CDKN1B', 'FYN']",0.9996167817520385,0,0,3
398,Pregnane X receptor pathway WP2876,0.7831016137394163,0.7213216255769447,0.17635795585457453,"['RXRA', 'CYP3A5', 'PPARGC1A']",0.9996167817520385,0,0,3
399,Regulation of apoptosis by parathyroid hormone-related protein WP3872,0.7831016137394163,0.7213216255769447,0.17635795585457453,"['BCL2L13', 'GSK3A', 'BCL2L15']",0.9996167817520385,0,0,3
400,Oncostatin M Signaling Pathway WP2374,0.7852575252459312,0.7946130736558583,0.1920925911509196,"['MAPK9', 'STAT5B', 'MAPK8', 'CDKN1B', 'PRKCE', 'RPS6', 'LIFR', 'KRAS', 'RAF1']",0.9996167817520385,0,0,9
401,Non-small cell lung cancer WP4255,0.7872836126438509,0.8064995666572919,0.19288785897106794,"['RB1', 'STAT5B', 'RXRA', 'AKT3', 'E2F1', 'RARB', 'KRAS', 'PIK3CB', 'RAF1', 'FOXO3', 'FHIT']",0.9996167817520385,0,0,11
402,DNA Replication WP466,0.7876491236448842,0.7635723660661019,0.18226668070198465,"['ORC5', 'POLA1', 'RFC2', 'ORC2', 'MCM3', 'UBA52']",0.9996167817520385,0,0,6
403,Thermogenesis WP4321,0.7969095100297051,0.8237384506041222,0.18700027995970095,"['PRKAA1', 'RPS6', 'PRKAG2', 'CPT1C', 'SMARCA2', 'ADCY5', 'RPTOR', 'LIPE', 'CREB3', 'RPS6KA6', 'RPS6KB1', 'RPS6KA2', 'PRDM16', 'KRAS', 'PRKACA', 'PPARGC1A']",0.9996167817520385,0,0,16
404,Aryl Hydrocarbon Receptor Pathway WP2873,0.798132645191334,0.7212274774774775,0.1626227129795989,"['CDKN1B', 'AIP', 'EP300', 'ARNT']",0.9996167817520385,0,0,4
405,Proteasome Degradation WP183,0.8022514373558933,0.7786598984771573,0.17156463285690773,"['PSMD12', 'PSMB5', 'PSMC6', 'PSMC3', 'PSMD2', 'NEDD4', 'PSMD3', 'PSME1', 'PSMB10']",0.9996167817520385,0,0,9
406,ERK Pathway in Huntington's Disease WP3853,0.8024028849441796,0.6658702539863918,0.14658763880218104,"['RAF1', 'GRM1']",0.9996167817520385,0,0,2
407,Mitochondrial complex III assembly WP4921,0.8024028849441796,0.6658702539863918,0.14658763880218104,"['UQCC3', 'CYC1']",0.9996167817520385,0,0,2
408,TP53 network WP1742,0.8024028849441796,0.6658702539863918,0.14658763880218104,"['ABL1', 'ATM']",0.9996167817520385,0,0,2
409,Vitamin D Receptor Pathway WP2877,0.8038573705418998,0.8298468556533073,0.1811833065222388,"['CEBPA', 'G6PD', 'TGFB2', 'CDKN1B', 'HILPDA', 'TNFAIP3', 'CDKAL1', 'GXYLT2', 'TRAK1', 'CYP3A5', 'CRACR2A', 'CEACAM1', 'RXRA', 'CLMN', 'DNER', 'SOSTDC1', 'CD14', 'HLA-DRB1', 'CD200']",0.9996167817520385,0,0,19
410,IL-6 signaling pathway WP364,0.8075850358904917,0.7416980585337584,0.15850600901316778,"['HCK', 'CREBBP', 'RPS6KB1', 'HDAC1', 'MAP3K7', 'NR2F6']",0.9996167817520385,0,0,6
411,Estrogen signaling pathway WP712,0.8098668425612003,0.6833040046925826,0.1440988634484303,"['MAPK9', 'SP1', 'PRKACA']",0.9996167817520385,0,0,3
412,Fatty Acid Biosynthesis WP357,0.8098668425612003,0.6833040046925826,0.1440988634484303,"['ACLY', 'ACSS2', 'ACACA']",0.9996167817520385,0,0,3
413,Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling WP3612,0.8098668425612003,0.6833040046925826,0.1440988634484303,"['MAPK8', 'SRXN1', 'EPHX1']",0.9996167817520385,0,0,3
414,Aspirin and miRNAs WP4707,0.8103936243030438,0.6183886987126946,0.1300070676852721,['PPARA'],0.9996167817520385,0,0,1
415,Canonical NF-KB pathway WP4562,0.8103936243030438,0.6183886987126946,0.1300070676852721,['NFKBIE'],0.9996167817520385,0,0,1
416,Estrogen metabolism WP697,0.8103936243030438,0.6183886987126946,0.1300070676852721,['COMT'],0.9996167817520385,0,0,1
417,Hijack of ubiquitination by SARS-CoV-2 WP4860,0.8103936243030438,0.6183886987126946,0.1300070676852721,['UBA3'],0.9996167817520385,0,0,1
418,Liver X receptor pathway WP2874,0.8103936243030438,0.6183886987126946,0.1300070676852721,['RXRA'],0.9996167817520385,0,0,1
419,NAD Biosynthesis II (from tryptophan) WP2485,0.8103936243030438,0.6183886987126946,0.1300070676852721,['NADSYN1'],0.9996167817520385,0,0,1
420,TFs regulate miRNAs related to cardiac hypertrophy WP1559,0.8103936243030438,0.6183886987126946,0.1300070676852721,['MYEF2'],0.9996167817520385,0,0,1
421,Vitamin D Metabolism WP1531,0.8103936243030438,0.6183886987126946,0.1300070676852721,['RXRA'],0.9996167817520385,0,0,1
422,Focal Adhesion-PI3K-Akt-mTOR-signaling pathway WP3932,0.8132458223126467,0.8722011401973406,0.18030303385724952,"['PHLPP2', 'ITGB1', 'PRKAA1', 'CDKN1B', 'PHLPP1', 'CHRM1', 'EPAS1', 'CAB39L', 'COL11A1', 'LAMA4', 'ITGA2B', 'LAMA3', 'PIK3R4', 'PTEN', 'IRS2', 'PIK3CB', 'FOXO3', 'ACACA', 'RPTOR', 'GYS2', 'LIPE', 'GYS1', 'PPP2R1B', 'AKT3', 'NOS1', 'PELO', 'PPARGC1A', 'RAB8A', 'INSR', 'RPS6', 'VEGFD', 'IGF1', 'PPP2R5C', 'PRLR', 'PTK2', 'EPOR', 'RAB10', 'CREB3', 'RPS6KB1', 'PPP2R2B', 'KIT', 'KRAS', 'RAF1']",0.9996167817520385,0,0,43
423,Toll-like Receptor Signaling Pathway WP75,0.8174401142919977,0.7799348259341709,0.1572174165605235,"['MAPK9', 'MAPK8', 'TRAF3', 'TOLLIP', 'AKT3', 'MAP3K8', 'CD14', 'PIK3CB', 'MAP3K7', 'IKBKE', 'MAP2K6']",0.9996167817520385,0,0,11
424,LncRNA involvement in canonical Wnt signaling and colorectal cancer WP4258,0.8177750625191943,0.7863389997536339,0.15818621629405738,"['FZD1', 'PORCN', 'HNRNPK', 'APC', 'CHD8', 'SERPINF1', 'FZD6', 'DVL2', 'FZD9', 'MAP3K7', 'CXXC4', 'LRP6']",0.9996167817520385,0,0,12
425,p53 transcriptional gene network WP4963,0.8182197258138385,0.7633323380113467,0.15314306558617707,"['PIDD1', 'TIGAR', 'APAF1', 'RRM2B', 'CCNG1', 'PTEN', 'ERCC5', 'ACAD11', 'CPT1C']",0.9996167817520385,0,0,9
426,IL-18 signaling pathway WP4754,0.8187098288063634,0.859433022371162,0.1719085692529216,"['SPON1', 'PRKAA1', 'PIGT', 'CD83', 'STOML1', 'TSHZ1', 'ITGA2B', 'COX17', 'PTEN', 'TNFAIP3', 'ENO1', 'FUT1', 'RPTOR', 'MAPK9', 'GRM7', 'LONP2', 'TRPM7', 'LRRFIP1', 'MAP3K7', 'KCNH2', 'ZNF143', 'CA11', 'SLC12A3', 'USP5', 'IMP3', 'FOXN3', 'GRIN2B', 'ARFGAP2', 'TF', 'RPS6KB1', 'SP1', 'NFKBIE', 'CDK5R2', 'SNTB1', 'ARF6', 'MYH7']",0.9996167817520385,0,0,36
427,B Cell Receptor Signaling Pathway WP23,0.8193892094038353,0.7966012488849242,0.15867984837565433,"['KLF11', 'GSK3A', 'NFATC3', 'CBL', 'RASGRP3', 'MAPK9', 'MAPK8', 'PIP5K1B', 'FYN', 'PTPN6', 'RAF1', 'MAP3K7', 'GTF2I', 'MAP2K6']",0.9996167817520385,0,0,14
428,Prader-Willi and Angelman Syndrome WP3998,0.8196569137312181,0.7523092310407719,0.1496113035714048,"['GABRB3', 'RB1', 'HERC2', 'E2F1', 'GNRH1', 'MDM4', 'GHRL', 'GABRD']",0.9996167817520385,0,0,8
429,Heart Development WP1591,0.8206504648561074,0.6923243243243243,0.13684344362051282,"['SMAD4', 'BHLHE40', 'NFATC3', 'BMPR1A']",0.9996167817520385,0,0,4
430,IL-4 signaling pathway WP395,0.8221252171584151,0.7385864051403449,0.14466142646863633,"['CEBPA', 'STAT5B', 'RPS6KB1', 'EP300', 'IRS2', 'PTPN6', 'CBL']",0.9996167817520385,0,0,7
431,Metapathway biotransformation Phase I and II WP702,0.8264756689155057,0.8132864899393165,0.15500004372160772,"['GSTM4', 'GSTK1', 'CHST9', 'GPX2', 'GPX3', 'GSTO1', 'AKR1C1', 'EPHX1', 'KCNAB1', 'COMT', 'CYP3A5', 'HS3ST4', 'HS2ST1', 'CYP2U1', 'CHST11', 'CYP4V2', 'NAT9', 'NAT8L', 'GSTM5']",0.9996167817520385,0,0,19
432,Cancer immunotherapy by PD-1 blockade WP4585,0.8311980929818746,0.6182598630269123,0.11430829382999366,"['NFATC3', 'HLA-DRB1']",0.9996167817520385,0,0,2
433,Glycosaminoglycan degradation WP4815,0.8311980929818746,0.6182598630269123,0.11430829382999366,"['GLB1', 'ARSB']",0.9996167817520385,0,0,2
434,NAD+ metabolism WP3644,0.8311980929818746,0.6182598630269123,0.11430829382999366,"['SIRT1', 'NADK']",0.9996167817520385,0,0,2
435,Serotonin and anxiety WP3947,0.8311980929818746,0.6182598630269123,0.11430829382999366,"['ADRA1A', 'GRM1']",0.9996167817520385,0,0,2
436,Kisspeptin/kisspeptin receptor system in the ovary WP4871,0.8319906321892282,0.6978163939430279,0.12835222871895408,"['PRKCE', 'KRAS', 'PIK3CB', 'ARRB2', 'RAF1']",0.9996167817520385,0,0,5
437,mBDNF and proBDNF regulation of GABA neurotransmission WP4829,0.8319906321892282,0.6978163939430279,0.12835222871895408,"['GABRB3', 'ROCK1', 'PTEN', 'PIK3CB', 'GABRD']",0.9996167817520385,0,0,5
438,TLR4 Signaling and Tolerance WP3851,0.8337823095223951,0.6490881458966565,0.11799314528294183,"['TRAF3', 'IKBKE', 'MAP3K7']",0.9996167817520385,0,0,3
439,Breast cancer pathway WP4262,0.8398908697011497,0.8104612640163099,0.1414119660853567,"['RB1', 'NOTCH2', 'FZD1', 'MRE11', 'NOTCH4', 'FZD6', 'FZD9', 'PTEN', 'IGF1', 'LRP6', 'DLL4', 'RPS6KB1', 'APC', 'SP1', 'AKT3', 'KIT', 'DVL2', 'E2F1', 'ATM', 'KRAS', 'RAF1']",0.9996167817520385,0,0,21
440,Fluoropyrimidine Activity WP1601,0.8410516581667656,0.6656444906444906,0.11522452322076529,"['SMUG1', 'DPYS', 'DPYD', 'TK1']",0.9996167817520385,0,0,4
441,GABA receptor Signaling WP4159,0.8410516581667656,0.6656444906444906,0.11522452322076529,"['GABRB3', 'GAD2', 'GABRD', 'GPHN']",0.9996167817520385,0,0,4
442,Interleukin-11 Signaling Pathway WP2332,0.8430312543355173,0.7014966284743162,0.11978142375310454,"['ATF1', 'YES1', 'RPS6KB1', 'RPS6', 'FYN', 'RAF1']",0.9996167817520385,0,0,6
443,Hippo-Merlin Signaling Dysregulation WP4541,0.8444677758125577,0.7860490933760947,0.13288057829415176,"['ITGB1', 'INSR', 'ITGA2B', 'PTK2', 'CDH7', 'CDH6', 'LATS1', 'CDH2', 'CDH20', 'PRKAR2A', 'CDH10', 'KIT', 'KRAS', 'PRKACA', 'PAK2', 'PAK5']",0.9996167817520385,0,0,16
444,ATR Signaling WP3875,0.8459873320215299,0.541047924400945,0.09049074875957204,['RAD9A'],0.9996167817520385,0,0,1
445,Mammary gland development pathway - Involution (Stage 4 of 4) WP2815,0.8459873320215299,0.541047924400945,0.09049074875957204,['E2F1'],0.9996167817520385,0,0,1
446,Small Ligand GPCRs WP247,0.8459873320215299,0.541047924400945,0.09049074875957204,['S1PR1'],0.9996167817520385,0,0,1
447,Tamoxifen metabolism WP691,0.8459873320215299,0.541047924400945,0.09049074875957204,['CYP3A5'],0.9996167817520385,0,0,1
448,Vitamin B12 Disorders WP4271,0.8459873320215299,0.541047924400945,0.09049074875957204,['TCN1'],0.9996167817520385,0,0,1
449,Oxidation by Cytochrome P450 WP43,0.8497260544822403,0.6759568266306184,0.11007366830865188,"['CYB5B', 'CYB5R4', 'CYP2U1', 'CYP4V2', 'CYP3A5']",0.9996167817520385,0,0,5
450,Oxidative Damage WP3941,0.8497260544822403,0.6759568266306184,0.11007366830865188,"['CDKN1B', 'MAP3K1', 'APAF1', 'TRAF3', 'NFKBIE']",0.9996167817520385,0,0,5
451,miRNAs involvement in the immune response in sepsis WP4329,0.855058616436607,0.6181309403193902,0.09679019101190518,"['MAPK8', 'TRAF3', 'MAP3K7']",0.9996167817520385,0,0,3
452,Nuclear Receptors in Lipid Metabolism and Toxicity WP299,0.855058616436607,0.6181309403193902,0.09679019101190518,"['ABCD3', 'RARB', 'PPARA']",0.9996167817520385,0,0,3
453,Type I interferon induction and signaling during SARS-CoV-2 infection WP4868,0.855058616436607,0.6181309403193902,0.09679019101190518,"['DDX58', 'TRAF3', 'IKBKE']",0.9996167817520385,0,0,3
454,EGFR Tyrosine Kinase Inhibitor Resistance WP4806,0.8554759274501436,0.7519736066925886,0.11738106818922797,"['RPS6KB1', 'AKT3', 'RPS6', 'PTEN', 'NF1', 'RRAS2', 'KRAS', 'PIK3CB', 'NRG2', 'IGF1', 'RAF1', 'FOXO3']",0.9996167817520385,0,0,12
455,"GPCRs, Class B Secretin-like WP334",0.8561479693313974,0.5769975241953635,0.08961467202669046,"['ADGRL2', 'ADGRL3']",0.9996167817520385,0,0,2
456,Mitochondrial LC-Fatty Acid Beta-Oxidation WP368,0.8561479693313974,0.5769975241953635,0.08961467202669046,"['ACADVL', 'SCP2']",0.9996167817520385,0,0,2
457,ncRNAs involved in Wnt signaling in hepatocellular carcinoma WP4336,0.8580239458097135,0.7329332246996316,0.1122291328012058,"['FZD1', 'PORCN', 'APC', 'CHD8', 'SERPINF1', 'FZD6', 'DVL2', 'FZD9', 'CXXC4', 'LRP6']",0.9996167817520385,0,0,10
458,Cholesterol metabolism (includes both Bloch and Kandutsch-Russell pathways) WP4718,0.858659810476427,0.682982811999573,0.10407460454858639,"['CH25H', 'EBP', 'HMGCS1', 'SOAT1', 'DHCR24', 'LBR']",0.9996167817520385,0,0,6
459,One-carbon metabolism and related pathways WP3940,0.858659810476427,0.682982811999573,0.10407460454858639,"['GPX2', 'GPX3', 'GAD2', 'CHPT1', 'CEPT1', 'GNMT']",0.9996167817520385,0,0,6
460,The influence of laminopathies on Wnt signaling WP4844,0.8594640947316363,0.6409409409409409,0.09706808892192316,"['CEBPA', 'APC', 'DICER1', 'EMD']",0.9996167817520385,0,0,4
461,Thyroid stimulating hormone (TSH) signaling pathway WP2032,0.8602203715776079,0.7207557811618726,0.10852180256618396,"['RB1', 'CDKN1B', 'RPS6KB1', 'GNAQ', 'RPS6', 'GNAI3', 'E2F1', 'RAF1', 'MAP2K6']",0.9996167817520385,0,0,9
462,ESC Pluripotency Pathways WP3931,0.8648593313724752,0.7628508168272395,0.11075709561035976,"['FZD1', 'SMAD4', 'FZD6', 'FZD9', 'PTEN', 'LIFR', 'SMAD5', 'LRP6', 'APC', 'AKT3', 'DVL2', 'RAF1', 'MAPK6', 'MAP2K6', 'BMPR1A']",0.9996167817520385,0,0,15
463,Vitamin A and carotenoid metabolism WP716,0.8658777035487157,0.6554220815795672,0.09438838284863663,"['RXRA', 'RETSAT', 'RDH12', 'ALDH1A1', 'RARB']",0.9996167817520385,0,0,5
464,Novel intracellular components of RIG-I-like receptor (RLR) pathway WP3865,0.8673947926441331,0.6880668367817505,0.09788511136337497,"['MAPK9', 'MAPK8', 'MAP3K1', 'DDX58', 'TRAF3', 'MAP3K7', 'IKBKE']",0.9996167817520385,0,0,7
465,Monoamine Transport WP727,0.8739119115118171,0.589988026158239,0.07951604694560796,"['HRH3', 'ADORA2A', 'NOS1']",0.9996167817520385,0,0,3
466,Striated Muscle Contraction Pathway WP383,0.8739119115118171,0.589988026158239,0.07951604694560796,"['MYBPC1', 'TNNT2', 'DMD']",0.9996167817520385,0,0,3
467,ACE Inhibitor Pathway WP554,0.8749010031212358,0.4808939888251397,0.06426885511512496,['ATP6AP2'],0.9996167817520385,0,0,1
468,Cytokines and Inflammatory Response WP530,0.8749010031212358,0.4808939888251397,0.06426885511512496,['HLA-DRB1'],0.9996167817520385,0,0,1
469,LTF danger signal response pathway WP4478,0.8749010031212358,0.4808939888251397,0.06426885511512496,['CD14'],0.9996167817520385,0,0,1
470,Non-homologous end joining WP438,0.8749010031212358,0.4808939888251397,0.06426885511512496,['DCLRE1C'],0.9996167817520385,0,0,1
471,Selective expression of chemokine receptors during T-cell polarization WP4494,0.8749010031212358,0.4808939888251397,0.06426885511512496,['TGFB2'],0.9996167817520385,0,0,1
472,Valproic acid pathway WP3871,0.8749010031212358,0.4808939888251397,0.06426885511512496,['HDAC1'],0.9996167817520385,0,0,1
473,BDNF-TrkB Signaling WP3676,0.8760220516839821,0.6180019305019305,0.08180121692713135,"['EEF2K', 'RPS6KB1', 'MKNK1', 'KRAS']",0.9996167817520385,0,0,4
474,Apoptosis Modulation by HSP70 WP384,0.8776812601468732,0.5408929777177582,0.07057126997292831,"['MAP3K1', 'APAF1']",0.9996167817520385,0,0,2
475,Host-pathogen interaction of human coronaviruses - autophagy WP4863,0.8776812601468732,0.5408929777177582,0.07057126997292831,"['PIK3R4', 'ATG10']",0.9996167817520385,0,0,2
476,Kynurenine Pathway and links to Cellular Senescence WP5044,0.8776812601468732,0.5408929777177582,0.07057126997292831,"['EIF2AK4', 'NOS1']",0.9996167817520385,0,0,2
477,Nicotine Activity on Dopaminergic Neurons WP1602,0.8776812601468732,0.5408929777177582,0.07057126997292831,"['PRKACA', 'DRD3']",0.9996167817520385,0,0,2
478,FGFR3 signaling in chondrocyte proliferation and terminal differentiation WP4767,0.8905573604822532,0.5642923219241444,0.0654058615781333,"['RBL1', 'SOX9', 'RAF1']",0.9996167817520385,0,0,3
479,Oxidative Stress WP408,0.8905573604822532,0.5642923219241444,0.0654058615781333,"['MAOA', 'GPX3', 'SP1']",0.9996167817520385,0,0,3
480,Toll-like Receptor Signaling related to MyD88 WP3858,0.8905573604822532,0.5642923219241444,0.0654058615781333,"['TRAF3', 'TOLLIP', 'IKBKE']",0.9996167817520385,0,0,3
481,White fat cell differentiation WP4149,0.8905573604822532,0.5642923219241444,0.0654058615781333,"['CEBPA', 'STAT5B', 'KLF15']",0.9996167817520385,0,0,3
482,Photodynamic therapy-induced HIF-1 survival signaling WP3614,0.8908624024913884,0.5966449207828518,0.06895144560145793,"['EGLN1', 'LDHA', 'PKM', 'ARNT']",0.9996167817520385,0,0,4
483,Pre-implantation embryo WP3527,0.8908624024913884,0.5966449207828518,0.06895144560145793,"['HMGA1', 'SOX11', 'ATP1A1', 'ZFP36L2']",0.9996167817520385,0,0,4
484,NRF2 pathway WP2884,0.8914193482976988,0.7434965932799347,0.08545773128611668,"['GSTM4', 'CBR1', 'G6PD', 'TGFB2', 'GPX2', 'SRXN1', 'GPX3', 'SLC39A12', 'SLC5A2', 'RXRA', 'PRDX1', 'SLC39A6', 'ME1', 'SLC39A1', 'FTL', 'GSTM5']",0.9996167817520385,0,0,16
485,Modulators of TCR signaling and T cell activation WP5072,0.8919580572165811,0.6580479628295423,0.07523868280212871,"['CDKN1B', 'ARIH2', 'TNFAIP3', 'CBLB', 'MAP3K8', 'PTPN6', 'MAP3K14']",0.9996167817520385,0,0,7
486,22q11.2 copy number variation syndrome WP4657,0.8930427878387209,0.7290177659791709,0.08246706163152487,"['PRKN', 'COMT', 'RTN4', 'ARNTL', 'HIRA', 'ARVCF', 'NCOR1', 'THAP7', 'DGCR6L', 'DROSHA', 'SHOC2', 'RAF1', 'HIST1H4C', 'TNPO1']",0.9996167817520385,0,0,14
487,PI3K/AKT/mTOR - VitD3 signaling WP4141,0.8962012468246005,0.5090360249434007,0.05578540325054162,"['LDHA', 'RXRA']",0.9996167817520385,0,0,2
488,RAS and bradykinin pathways in COVID-19 WP4969,0.8962012468246005,0.5090360249434007,0.05578540325054162,"['ROCK1', 'NOS1']",0.9996167817520385,0,0,2
489,Serotonin Receptor 4/6/7 and NR3C Signaling WP734,0.8962012468246005,0.5090360249434007,0.05578540325054162,"['ATF1', 'MAPKAPK2']",0.9996167817520385,0,0,2
490,Cells and molecules involved in local acute inflammatory response  WP4493,0.8983879649298288,0.4327708403644954,0.046372811468738874,['ITGB1'],0.9996167817520385,0,0,1
491,Mevalonate arm of cholesterol biosynthesis pathway WP4190,0.8983879649298288,0.4327708403644954,0.046372811468738874,['HMGCS1'],0.9996167817520385,0,0,1
492,Osteopontin Signaling WP1434,0.8983879649298288,0.4327708403644954,0.046372811468738874,['MAP3K14'],0.9996167817520385,0,0,1
493,Purine metabolism WP4792,0.8983879649298288,0.4327708403644954,0.046372811468738874,['PRPS1'],0.9996167817520385,0,0,1
494,Microglia Pathogen Phagocytosis Pathway WP3937,0.90412155920465,0.5767117117117118,0.05812761512450946,"['HCK', 'RAC3', 'PTPN6', 'PIK3CB']",0.9996167817520385,0,0,4
495,Resistin as a regulator of inflammation WP4481,0.9052043140036372,0.5407379263762242,0.05385457717538949,"['AKT3', 'ITPR1', 'PIK3CB']",0.9996167817520385,0,0,3
496,Urea cycle and metabolism of amino groups WP497,0.9120802066497853,0.4807187335884162,0.04423926965097056,"['CPS1', 'ALDH18A1']",0.9996167817520385,0,0,2
497,Bladder cancer WP2828,0.9159330791631806,0.5580645161290323,0.049004747148390995,"['RB1', 'E2F1', 'KRAS', 'RAF1']",0.9996167817520385,0,0,4
498,Endometrial cancer WP4155,0.9166181800450962,0.6404550694131208,0.05576075493387055,"['APC', 'AKT3', 'PTEN', 'ILK', 'KRAS', 'PIK3CB', 'RAF1', 'FOXO3']",0.9996167817520385,0,0,8
499,BMP2-WNT4-FOXO1 pathway in primary endometrial stromal cell differentiation WP3876,0.9174664566482217,0.393397355260332,0.03388695676642578,['SMAD5'],0.9996167817520385,0,0,1
500,Platelet-mediated interactions with vascular and circulating cells WP4462,0.9174664566482217,0.393397355260332,0.03388695676642578,['TGFB2'],0.9996167817520385,0,0,1
501,Serotonin and anxiety-related events WP3944,0.9174664566482217,0.393397355260332,0.03388695676642578,['NLGN1'],0.9996167817520385,0,0,1
502,Hair Follicle Development: Organogenesis - Part 2 of 3 WP2839,0.9180528709913194,0.5190678824721378,0.04438045777590833,"['ITGB1', 'FZD1', 'NCAM1']",0.9996167817520385,0,0,3
503,Electron Transport Chain (OXPHOS system in mitochondria) WP111,0.9197019711755675,0.6823384681215233,0.057115554831172026,"['COX8A', 'NDUFB9', 'SURF1', 'COX17', 'NDUFS4', 'NDUFS3', 'COX6A1', 'COX5B', 'SLC25A4', 'COX5A', 'ATP5F1D', 'SLC25A6']",0.9996167817520385,0,0,12
504,IL-9 signaling pathway WP22,0.9329637129216433,0.3605861176735291,0.02502069994855262,['STAT5B'],0.9996167817520385,0,0,1
505,Nucleotide Excision Repair WP4753,0.9349032621560237,0.5543279520974689,0.03731304394445895,"['RFC2', 'XPA', 'RAD23A', 'ERCC5', 'ERCC6']",0.9996167817520385,0,0,5
506,SARS-CoV-2 innate immunity evasion and cell-specific immune response WP5039,0.9349032621560237,0.5543279520974689,0.03731304394445895,"['AP1G1', 'DDX58', 'TRAF3', 'CXCL17', 'EP300']",0.9996167817520385,0,0,5
507,"GPCRs, Class A Rhodopsin-like WP455",0.9350693846924943,0.7067024625069431,0.047444147719186126,"['OPRD1', 'CHRM3', 'NPFFR1', 'RABGAP1', 'P2RY11', 'CHRM1', 'GPR52', 'GPR63', 'OPRL1', 'OPRM1', 'SSTR1', 'ADRA1A', 'SSTR3', 'ADRA2A', 'MC4R', 'HRH3', 'ADORA2A', 'DRD3']",0.9996167817520385,0,0,18
508,Oxidative phosphorylation WP623,0.9355627066682138,0.5764255127338291,0.03839403488426306,"['NDUFB9', 'ATP6AP1', 'ATP6AP2', 'NDUFS4', 'NDUFS3', 'ATP5F1D']",0.9996167817520385,0,0,6
509,Translation Factors WP107,0.9355627066682138,0.5764255127338291,0.03839403488426306,"['EIF4A2', 'EEF1G', 'EEF2K', 'EIF1AY', 'EIF1AX', 'EIF4G1']",0.9996167817520385,0,0,6
510,Focal Adhesion WP306,0.9357445492858427,0.7470535082894634,0.04961388324869106,"['ITGB1', 'ROCK1', 'LAMA4', 'ITGA2B', 'LAMA3', 'PTEN', 'ILK', 'PIK3CB', 'ARHGAP35', 'MYLK4', 'MAPK9', 'MAPK8', 'AKT3', 'CAPN2', 'RAC3', 'FLNB', 'FYN', 'PAK2', 'CAV3', 'CAV2', 'ACTN1', 'VEGFD', 'IGF1', 'PTK2', 'HCK', 'RAF1', 'PPP1R12B']",0.9996167817520385,0,0,27
511,Unfolded protein response WP4925,0.9372357961576241,0.4325793382849426,0.028039956346957683,"['HSPA5', 'ATF6']",0.9996167817520385,0,0,2
512,Fibrin Complement Receptor 3 Signaling Pathway WP4136,0.9390959596530035,0.4805433599759841,0.030196196983062074,"['PLG', 'CBLB', 'CD14']",0.9996167817520385,0,0,3
513,Nucleotide-binding Oligomerization Domain (NOD) pathway WP1433,0.9390959596530035,0.4805433599759841,0.030196196983062074,"['COPS6', 'ERBIN', 'AAMP']",0.9996167817520385,0,0,3
514,Tumor suppressor activity of SMARCB1 WP4204,0.9390959596530035,0.4805433599759841,0.030196196983062074,"['RB1', 'GLI4', 'EED']",0.9996167817520385,0,0,3
515,Ferroptosis WP4313,0.9439397862231768,0.5087042925278219,0.029348626209834257,"['MAP1LC3B', 'TF', 'SAT2', 'FTL']",0.9996167817520385,0,0,4
516,Mammalian disorder of sexual development WP4842,0.945551783371011,0.33282276279238815,0.0186336229267768,['SOX9'],0.9996167817520385,0,0,1
517,Mammary gland development pathway - Embryonic development (Stage 1 of 4) WP2813,0.945551783371011,0.33282276279238815,0.0186336229267768,['ITGB1'],0.9996167817520385,0,0,1
518,Phytochemical activity on NRF2 transcriptional activation WP3,0.945551783371011,0.33282276279238815,0.0186336229267768,['MAPK8'],0.9996167817520385,0,0,1
519,PPAR signaling pathway WP3942,0.9492721879143655,0.5518104527210738,0.028727089931301672,"['RXRA', 'SCP2', 'ME1', 'ILK', 'CPT1C', 'PPARA']",0.9996167817520385,0,0,6
520,Alpha 6 Beta 4 signaling pathway WP244,0.9550353648395441,0.44733256472067917,0.02058038812431725,"['LAMA3', 'IRS2', 'PTK2']",0.9996167817520385,0,0,3
521,Fatty acid beta-oxidation WP143,0.9550353648395441,0.44733256472067917,0.02058038812431725,"['LIPE', 'ACADVL', 'ACSS2']",0.9996167817520385,0,0,3
522,TYROBP causal network in microglia WP3945,0.9556800372623084,0.5146124012295016,0.023328466498516356,"['FKBP15', 'RGS1', 'DPYD', 'ZFP36L2', 'IL13RA1']",0.9996167817520385,0,0,5
523,Cholesterol Biosynthesis Pathway WP197,0.955776636530669,0.30902560146569596,0.01397754842189879,['HMGCS1'],0.9996167817520385,0,0,1
524,Dopaminergic Neurogenesis WP2855,0.955776636530669,0.30902560146569596,0.01397754842189879,['ALDH1A1'],0.9996167817520385,0,0,1
525,Tryptophan catabolism leading to NAD+ production WP4210,0.955776636530669,0.30902560146569596,0.01397754842189879,['NADSYN1'],0.9996167817520385,0,0,1
526,Apoptosis WP254,0.9607831449852894,0.5666496594866789,0.022669698534434315,"['MAP3K1', 'APAF1', 'TRAF3', 'IRF2', 'TNFRSF25', 'IGF1', 'NFKBIE', 'TNFRSF21']",0.9996167817520385,0,0,8
527,Cytosolic DNA-sensing pathway WP4655,0.9611277048517909,0.5026053742229069,0.01992729354360544,"['DDX58', 'CCL4L2', 'POLR1C', 'POLR3H', 'IKBKE']",0.9996167817520385,0,0,5
528,NOTCH1 regulation of endothelial cell calcification WP3413,0.9640818067923486,0.28840139498256273,0.010549471010161385,['DLL4'],0.9996167817520385,0,0,1
529,Tryptophan metabolism WP465,0.9670007494157725,0.4184070333692846,0.014040069984385744,"['ALDH1A1', 'OGDH', 'DHCR24']",0.9996167817520385,0,0,3
530,Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4) WP2817,0.9685443461461614,0.36037024532973216,0.01151779654618993,"['CEBPA', 'PRLR']",0.9996167817520385,0,0,2
531,FGF23 signaling in hypophosphatemic rickets and related disorders WP4790,0.9708276079336797,0.2703552143098211,0.008004235749574871,['ROS1'],0.9996167817520385,0,0,1
532,nsp1 from SARS-CoV-2 inhibits translation initiation in the host cell WP5027,0.9708276079336797,0.2703552143098211,0.008004235749574871,['EIF1AX'],0.9996167817520385,0,0,1
533,Chemokine signaling pathway WP3929,0.9711145867690011,0.6335627948663688,0.018570237830621894,"['STAT5B', 'ROCK1', 'GNAI3', 'ARRB2', 'PIK3CB', 'FOXO3', 'RASGRP2', 'PTK2', 'ADCY5', 'TIAM2', 'TIAM1', 'HCK', 'AKT3', 'CSK', 'KRAS', 'RAF1']",0.9996167817520385,0,0,16
534,Vitamin B12 metabolism WP1533,0.9717883053340823,0.40530015197568386,0.011598592435277267,"['TCN1', 'INSR', 'PLG']",0.9996167817520385,0,0,3
535,Regulatory circuits of the STAT3 signaling pathway WP4538,0.972242009282841,0.5214103296677667,0.014677974399914187,"['RPTOR', 'PTPRD', 'MAPK9', 'MAPK8', 'CREBBP', 'LIFR', 'MAPK6']",0.9996167817520385,0,0,7
536,DNA Repair Pathways Full Network WP4946,0.9723769464380602,0.62255458173566,0.01743884001858324,"['MRE11', 'DCLRE1C', 'RFC2', 'XPA', 'APEX2', 'RAD23A', 'FANCB', 'SMUG1', 'RAD52', 'BRIP1', 'USP1', 'ATM', 'ERCC5', 'ERCC6', 'FAN1']",0.9996167817520385,0,0,15
537,Complement system WP2806,0.9752292200787187,0.5316123659831373,0.01333429374600968,"['RPS19', 'ITGA2B', 'F11', 'GNAI3', 'PLG', 'CD59', 'ARRB2', 'PRKACA']",0.9996167817520385,0,0,8
538,Corticotropin-releasing hormone signaling pathway WP2355,0.9753494732747132,0.5474512046900694,0.013664074444486697,"['MAPK9', 'MAPK8', 'SP1', 'GNAQ', 'ARRB2', 'RAF1', 'RAPGEF3', 'ACACA', 'PTK2']",0.9996167817520385,0,0,9
539,Differentiation Pathway WP2848,0.9759121276991396,0.3929876270301802,0.009582111092163533,"['TF', 'KIT', 'IGF1']",0.9996167817520385,0,0,3
540,"Non-genomic actions of 1,25 dihydroxyvitamin D3 WP4341",0.9760702000401784,0.48911171495273453,0.011846661806786903,"['MAPK9', 'MAPK8', 'RXRA', 'SP1', 'PRKCE', 'KRAS']",0.9996167817520385,0,0,6
541,Interactions between immune cells and microRNAs in tumor microenvironment WP4559,0.9763067435537859,0.2544321137162256,0.006100889121252764,['TGFB2'],0.9996167817520385,0,0,1
542,Lung fibrosis WP3624,0.9794582122699986,0.38139936825794146,0.007916212704152992,"['MECP2', 'RTEL1', 'IGF1']",0.9996167817520385,0,0,3
543,Host-pathogen interaction of human coronaviruses - apoptosis WP4864,0.9807569899485723,0.24027824652191848,0.004668742512840186,['APAF1'],0.9996167817520385,0,0,1
544,miRNA targets in ECM and membrane receptors WP2911,0.9807569899485723,0.24027824652191848,0.004668742512840186,['LAMA4'],0.9996167817520385,0,0,1
545,FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma WP4553,0.9843715006850409,0.22761426008490684,0.0035853597570410685,['EED'],0.9996167817520385,0,0,1
546,Globo Sphingolipid Metabolism WP1424,0.9843715006850409,0.22761426008490684,0.0035853597570410685,['FUT1'],0.9996167817520385,0,0,1
547,Base Excision Repair WP4752,0.9845124071650436,0.30879232179029614,0.004819870946690854,"['SMUG1', 'APEX2']",0.9996167817520385,0,0,2
548,Eicosanoid Synthesis WP167,0.9873071788098703,0.21621667229159636,0.0027619654448866274,['PTGES2'],0.9996167817520385,0,0,1
549,Immune response to tuberculosis WP4197,0.9873071788098703,0.21621667229159636,0.0027619654448866274,['IFIT3'],0.9996167817520385,0,0,1
550,Kallmann's Syndrome WP5074,0.9873071788098703,0.21621667229159636,0.0027619654448866274,['GNRH1'],0.9996167817520385,0,0,1
551,Statin inhibition of cholesterol production WP430,0.9873071788098703,0.21621667229159636,0.0027619654448866274,['SOAT1'],0.9996167817520385,0,0,1
552,Eicosanoid metabolism via lipooxygenases (LOX) WP4721,0.9896914779754868,0.20590456905002974,0.002133587845594309,['PPARA'],0.9996167817520385,0,0,1
553,DNA Mismatch Repair WP531,0.9916279285003023,0.1965299297395146,0.0016522888554038708,['RFC2'],0.9996167817520385,0,0,1
554,Photodynamic therapy-induced AP-1 survival signaling. WP3611,0.9922761303342813,0.3240374873353597,0.0025125391209348206,"['RB1', 'MAPK8', 'MAP2K6']",0.9996167817520385,0,0,3
555,PI3K-Akt signaling pathway WP4172,0.9932639709153903,0.6619903320722993,0.004474272520712622,"['PHLPP2', 'ITGB1', 'PRKAA1', 'CDKN1B', 'PHLPP1', 'CHRM1', 'LAMA4', 'ITGA2B', 'LAMA3', 'PTEN', 'PPP2R2A', 'PIK3CB', 'FOXO3', 'RPTOR', 'GYS2', 'GYS1', 'PPP2R1B', 'AKT3', 'THEM4', 'INSR', 'RPS6', 'VEGFD', 'IGF1', 'PPP2R5C', 'PRLR', 'PTK2', 'EPOR', 'CREB3', 'CCNE2', 'RPS6KB1', 'PPP2R2B', 'KIT', 'COL4A5', 'KRAS', 'SGK1', 'RAF1']",0.9996167817520385,0,0,36
556,Complement and Coagulation Cascades WP558,0.9934599715573188,0.3161094224924012,0.0020741545462122876,"['CLTC', 'PLG', 'F5']",0.9996167817520385,0,0,3
557,Gastric Cancer Network 2 WP2363,0.9955151779184281,0.17290583867701653,0.0007771960218872453,['LBR'],0.9996167817520385,0,0,1
558,Type II interferon signaling (IFNG) WP619,0.9963575836022336,0.16624263350554272,0.0006066303664001245,['IRF2'],0.9996167817520385,0,0,1
559,Hepatitis C and Hepatocellular Carcinoma WP3646,0.9979278571109278,0.22150660503125055,0.00045946954434807096,"['MAPK8', 'SMAD4']",0.9996167817520385,0,0,2
560,Allograft Rejection WP2328,0.9996167817520385,0.17984751294170606,6.893405804800736e-05,"['LRRK2', 'HLA-DRB1']",0.9996167817520385,0,0,2
